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                                           ABSTRACT 
 
Nonalcoholic fatty liver disease (NAFLD) is a metabolic manifestation of liver disease, 
characterized by lipid accumulation in hepatocytes. Despite starting as a benign disorder, 
NAFLD can progress to more severe pathologies such as nonalcoholic steatohepatitis, fibrosis, 
cirrhosis, and eventually hepatocellular carcinoma. The epidemiological prevalence of this 
disease is 25 % of the general population, and its worsening suggests that NAFLD is supposed 
to be the main cause for liver transplantation. NAFLD pharmacological treatment is still 
limited by unwanted side effects, whereas the best therapeutical approach is a lifestyle that 
depends on physical exercises and a healthy diet. The use of  natural-derived compounds with 
therapeutic potential is advisable. Recently, medicinal plants applications have been focused 
on  renewable sources as marine algae, especially seaweeds. Seaweeds are characterized with 
huge amounts of phytochemicals such as fucoidan (FUC) polysaccharide, which is known for 
its antioxidant, anti-inflammatory, anti-cancer, and hepatoprotective effects. In the present 
work, we extracted a water soluble fucoidan fraction from the brown algae Cystoseira 
compressa, and for the first time from the roots of the terrestrial shrub Ferula hermonis. These 
fucoidan fraction were termed CYS and FER, respectively. Then together with a previously 
purified fucoidan from the terrestrial plant Eucalyptus globulus “EUC” were studied and 
compared for their chemical features and biological activities. CYS, FER, and EUC contained 
fucose, glucose, sulfate, smaller amounts of monosaccharides such as galactose and mannose, 
and a minor quantity of proteins. FUCs structural features were investigated by FTIR, 1H 
NMR and 13C NMR spectroscopy. The antioxidant properties of FUCs were measured by 
DPPH, ABTS and FRAP assays, results revealed a high radical scavenging capacity that was 
confirmed in in vitro cellular models. In hepatic and endothelial cells, FUC reduced ROS 
production induced by intracellular lipid accumulation. Moreover, in our NAFLD model that 
consists of hepatic and endothelial cells treated with a fatty acid mixture prior to the FUCs 
treatment, FUCs purified from the three vegetal species exhibited a significant antisteatotic 
action; being able to reduce intracellular triglyceride content and to regulate the expression of 
key genes of hepatic lipid metabolism. Altogether, our results candidate CYS, FER, and EUC 
as  possible bioactive compounds against fatty liver disease and related vascular damage. 
Results indicated that among the purified FUCs, that purified from the terrestrial plant E. 
globulus was the most biologically active extract.  
 
 





























Table of Content  
 
List of Tables……………………………………………………………………………..….12 
List of Figures………………………………………………………………………………..13 
List of Abbreviations…………………...……………………………………………………14 
List of Supplementary Boxes………………………………………………………………..16 
Summary…………………………………………………………………………………….17 
Chapter I: Extraction and Chemical Characterization of Fucoidan 
Polysaccharide……………………………….........................................................................20 
Chapter II: Investigating and Comparing the Antioxidant Activity of Fucoidan Extracted from 
C. compressa,  F. hermonis, and E. globulus………………….……………………………..54 
Chapter III: Anti-Steatotic and Antioxidant Activities comparison of marine derived Fucoidan 
(C. compressa) and terrestrial fucoidans (F. hermonis, and E. globulus)……………………70 
General Conclusions………………………………………………………….………….…132 
References…..……………………………………………………………………………...135 



















List of Tables 
 
Table1: Source and nutritional value of the most known edible seaweeds. 
Table 2:  Chemical composition (%) of fucoidan extracted from C. compressa, F. hermonis, 
and E. globulus Data are presented as mean ± SD of 3 experiments. 
Table 3: Advantages and disadvantages of antioxidant quantification methods. 
 Table 4: Antioxidant activities of CYS, FER, and EUC measured by ABTS and FRAP assays. 
Table 5: function of several proteins synthesized by the liver. 
Table 6: Examples on different functions of fatty acids. 
Table 7: Parameters tested in NAFLD diagnosis. 
Table 8: Several studies targeting PPARs to ameliorate NAFLD in different models. 
Table 9: Concentrations of glycerol standard for TAG quantification.  
Table 10: Preparation of BSA concentrations used for protein quantification. 
Table 11: Primer pair sequences and annealing temperature.  



















  List of figures  
Figure 1: Worldwide temporal evolution of medical plants publications 
Figure 2: Diagram showing the classification of countries into three groups based on the number of 
publications related to traditional medicine.  
Figure 3: Cloud word of keywords related to medical plants publications. If keywords are extracted 
from the total number of publications, an overview can be made of the most used keywords in relation 
to traditional medicine. The most indexed terms are human, non-human, unclassified drugs, plant 
extract, plants, medicinal, mouse, animal, chemistry, and many other keywords.  
Figure 4: Chemical structure of brown algal polysaccharides: fucoidan, alginate, and laminarin (El 
Rashed et al., 2020).  
Figure 5: Map showing the sites of collection of the seaweeds along the Lebanese Coast 
Figure 6: Extraction of fucoidan polysaccharide.  
Figure 7: FTIR spectrum of fucoidan isolated from C. compressa (A) and F. hermonis (B).  
Figure 8: 1H NMR and 13 C NMR spectra of fucoidan isolated from F. hermonis. and C. compressa  
Figure 9: DPPH radical scavenging activity of CYS, FER, and EUC as a function of increased  FUC 
concentration in µg/ml.  
Figure 10: Anti-hemolytic activity of CYS, FER and EUC at a concentration 50 µg/ml. 
Figure 11: Anatomy of Liver (A); The structure of hepatic lobule (B). 
Figure 12: A diagram showing different liver functions.  
Figure 13: Hepatic lipogenesis. Malonyl-CoA is condensed with several acetyl-CoA moieties by FAS 
to produce fatty acid in the presence of NADPH as reducing agent.   
Figure 14: Diagram showing lipolysis steps and enzymes. 
Figure 15: Lipid accumulation within different organs; liver, heart, and kidney.  
Figure 16: Mitochondrial contribution to NAFLD pathogenesis.  
Figure 17: MTT cell viability assay steps.  
Figure 18: Representative Diagram of a simple UV-Visible Spectrophotometer.  
Figure 19: Principle of “Triglyceride kit”. Compound represented in pink color are all reagents  within 
the kit. 
Figure 20: DCF assay based on the oxidation of DCF-DA by ROS (mainly H2O2) into a fluorescent 
DCF molecule.  
Figure 21: The mechanism for the nitrite, sulfanilamide, and NED reaction.  
Figure 22: MTT assay results on FaO cells 
Figure 23: Results of ROS production  in steatotic FaO cells measured by DCF assay.  
Figure 24: TAG content quantification in FaO cells.  
Figure 25: A-Lipid droplet analysis by BODIPY staining in FaO cells.   
Figure 26: Effects of CYS, FER and EUC on hepatic gene expression. 
Figure 27: MTT assay results on HECV cells.  
Figure 28: ROS production measured by DCF assay in HECV cells.  
Figure 29: Representative images of DCF staining (green) to monitor ROS production in HECV cells 
Figure 30: TAG content quantification in HECV cells.  
Figure 31: Lipid droplet analysis by BODIPY staining in HECV cells. 






     List of Abbreviations  
13C NMR: Carbon NMR 
1H NMR: Proton NMR 
ABTS: 2,2'-azino-bis 3-ethylbenzothiazoline-6-sulphonic acid 
ACC: acetyl-CoA carboxylase 
ADP: Adenosine diphosphate 
ADRP: Adipose differentiation-related protein. 
ALG: Alginate            
ApoB: Apoprotein B  
ATGL: Adipose triglyceride lipase 
ATP: Adenosine triphosphate 
BAP: Brown algal polysaccharide  
BSA: Bovine serum albumin 
C: Control 
CPT-1: Carnitine-palmitoyltransferase-1  
CTP: Citrate transport protein 
CYPs: Cytochrome P450   
CYS: Fucoidan purified from C. compressa 
DAG: Diacylglycerol 
DAPI: 4′,6-diamidino-2-phenylindole  
DCF: 2′-7′dichlorofluorescein 
DMEM: Dulbecco's modified minimum essential medium 
DNL: De novo lipogenesis 
DPPH: 1,1-diphenyl-2-picrylhydrazyl 
ED: Endothelial dysfunction 
ER: Endoplasmic reticulum 
ETC: Electron transport chain 
EUC: Fucoidan purified from E. globulus 
F12: Coon’s modified Ham’s medium 
FA:  Fatty acid 
FADH2: Flavin adenine dinucleotide 
FaO: Rat hepatoma cells  
FAS : Fatty acyl synthetase 
Fe2+: Ferrous ion 
Fe3+:  Ferric ion  
FER: Fucoidan purified from F. hermonis 
FFA: Free fatty acid 
FRAP: Ferric Reducing Antioxidant Power  
FTIR: Fourier Transform Infrared spectroscopy 
FUC: Fucoidan 
GDP: guanosine diphosphate 





H2O2: Hydrogen peroxide  
HCl : Hydrochloric acid  
HECV: Endothelial cells isolated from the umbilical vein 
HFD: high fat diet  
HSL: Hormone sensitive lipase 
IFN-γ: Interferon gamma 
IL-6: Interleukin 6 
iNOS: Inducible nitric oxide synthase  
LAM: Laminarin 
LD: Lipid droplet 
LMWF: Low molecular weight fucoidan  
MAG: Monoacylglycerol 
MGL: Monoglyceride lipase  
MS: Metabolic syndrome 
mtDNA: Mitochondrial DNA 
MTT: 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide 
NADH: Nicotinamide adenine dinucleotide  
NADPH: Nicotinamide adenine dinucleotide phosphate  
NAFLD: Nonalcoholic fatty liver disease.  
NASH: Non-alcoholic steatohepatitis  
NMR: Nuclear Magnetic Resonance Spectroscopy 
NO: Nitric oxide 
OH: Hydroxyl group  
OP: Oleate/Palmitate 
OS :Oxidative stress 
PBS: Phosphate-buffered saline  
PKA: Protein kinase A    
PPARs: Peroxisome Proliferated Activated Receptors 
PUFA: Polyunsaturated fatty acid              
qPCR: Quantitative polymerase chain reaction 
RNS: Reactive nitrogen species 
ROS: Reactive oxygen species 
ROS: Reactive oxygen species  
RS: Reactive species  
SCFA: Short chain fatty acid 
SOD: Superoxide dismutase 
SREBP-1: Sterol regulatory element binding protein-1 
TAG: Triacylglycerol  
TIP-47: Tail-interacting protein of 47 kDa  
TNF-α: Tumor necrosis factor 
VLDL: Very-low-density lipoprotein 
β-oxidation: beta oxidation 





     List of Supplementary Boxes  
 
Box 1: Seaweed Cultivation  
Box 2: Fucoidan Pharmacokinetics 
Box 3: Antioxidant Enzymes 
Box 4: Cell Types of the Liver 
Box 5: Cholesterol Synthesis  
Box 6: Krebs Cycle 
Box 7: Lipogenesis and Lipolysis Regulation  

























Being first described in 1980’s, NAFLD was defined as the accumulation of lipids in more than 
5% of hepatocytes in the absence of excessive alcohol use or a direct cause for hepatic steatosis 
(Lindenmeyer et al., 2018). NAFLD is a widely spread disease, its prevalence is affected by 
several parameters such as body fat distribution, body composition, gender, age, and obesity 
(Souza et al., 2012). Studies have reported that NAFLD affects around 25-30% of the general 
population. However, this percentage increased to 57-74% in obese adults. Thus, patients with 
obesity, type 2 diabetes, dyslipidemia, and hypertension are at higher risk for NAFLD 
development compared to healthy people (Tarantino et al., 2007).  
 
NAFLD pathogenesis initiates as hepatic triglyceride accumulation is considered to be a 
relatively benign condition, a second hit increases the susceptibility to liver injury mediated by 
inflammation, oxidative stress, and mitochondrial dysfunction leading to nonalcoholic 
steatohepatitis NASH, a severe form of steatosis. Moreover, a third hit is implicated in further 
pathogenesis due to inadequate hepatocytes infiltration which is strongly correlated with 
fibrosis, and hepatocellular carcinoma (DOWMAN et al., 2009).  
 
Lipid homeostasis is regulated by different genes and pathways that are classified into four major 
sources leading  to steatosis: increased de novo lipogenesis (DNL), increased free fatty acids 
(FFAs), reduced FFA oxidation, and decreased secretion of triacylglycerols (TAGs); any 
disruption can cause an imbalance between lipid acquisition and disposal resulting in fat 
accumulation (Vecchione et al., 2016).   
 
Several drugs have been used to treat NAFLD and ameliorate metabolic functions, such as 
thiazolidinediones, metformin, statins, and fibrates, but still limited due to their side effects. The 
most effective approach is a lifestyle depending on lowering calories intake by dietary 
modification and enhancing physical activities as well as searching for natural agents and 
phytochemicals that can be effective in treating NAFLD through their anti-steatotic, anti-oxidant 
and anti-inflammatory capacities as shown previously (Baselga-Escudero et al., 2017; Yao et 
al., 2016).  
 
Due to the harsh environment that marine algae are forced to resist, they produce a wide range 
of biologically active compounds such as polysaccharides, vitamins, minerals, antioxidants, 
enzymes, and polyunsaturated fatty acids (Şükran et al., 2017). Fucoidan (FUC) is a fucose-rich 
sulfated polysaccharide with a backbone of α-(1–3)-linked fucose units or α-(1–3) - and α-(1–4) 





as xylose, mannose, galactose, glucose and uronic acid. (Guangling et al., 2011).  FUC is 
abundant in the cell wall of marine brown algae, also found in marine invertebrates such as sea 
urchin and sea cucumber (Pomin, 2012). FUCs have gained a great interest in research due to 
their antioxidant, anti-inflammatory, anti-viral, and anti-steatotic effects (Fitton et al., 2015).  
 
FUC structure is highly variable depending on several factors such as extraction method, 
variation in season of collection, geographical location, population age and species type. 
Structural difference is characterized also by variation in monosaccharide composition, sulfate 
content, sugar binding residues and molecular weight, all leading to different biological 
potentials (Yu Wang et al., 2019). 
 
Previously FUC has been purified from the brown algae Cystoseira compressa which is a brown 
algae species from Cystoseira genus, belongs to the family of Sargassaceae in the order of 
Fucales. However, Haddad et al identified FUC in the terrestrial tree Eucalyptus globulus 
(Haddad et al., 2017), also known as the blue gum, is an evergreen plant that belongs to the 
family of Myrtaceae. It rapidly grows especially in countries with Mediterranean-type climate. 
E. globulus is characterized by biological activities of potential medicinal value which make it 
of great interest (Qabaha et al., 2016).  
 
 
AIM OF THE STUDY   
 
1- The aim of this study is to extract FUC polysaccharide from the brown algae C. 
compressa (CYS) collected from the Lebanese coast and the terrestrial plant F. hermonis 
(FER) for the first time. Then to chemically characterize the purified FUC, and together 
with FUC purified from E. globulus (EUC) study their chemical composition.  
 
2- Investigate and compare the antioxidant potentials of CYS, FER, and EUC; 
spectrophotometrically  
 
3- After extraction and chemical features analysis we aimed to study and compare the anti-
steatotic and antioxidant activity of FUC of marine algal source  (CYS) with those 





1- For the first aim, structural features were analyzed by Fourier Transform Infrared 
spectroscopy and Nuclear magnetic resonance; in addition to the chemical composition 






2- Antioxidant activities were determined by ; DPPH (1,1-diphenyl-2-picrylhydrazyl) 
assay, ABTS (2,2-azinobis-3-ethylbenzothiazoline-6-sulfonic acid) assay,  FRAP (Ferric 
Reducing Antioxidant Power) assay, and anti-hemolysis assay. 
 
 
3- For the aim, two in vitro cellular models were used; rat hepatoma FaO cells exposed to 
an oleate/palmitate mixture representing a reliable in vitro model for hepatic steatosis as 
previously described by our group (Grasselli et al., 2017), and human endothelial HECV 











Results indicated that CYS and FER extracts showed the structural features and functional 
groups that characterize fucoidan polysaccharide. CYS, FER, and EUC possess a great 
antioxidant activity. Furthermore, FUC purified from three different species ameliorated lipid 
accumulation in hepatic cells, regulate lipid metabolism, and reduce oxidative stress in hepatic 







Fucoidan purified from seaweeds or terrestrial plants displays a protective effect against 
oxidative damage in erythrocytes, hepatocytes, and endothelial cells. This candidate C. 
compressa,  F. hermonis, and E. globulus species as sources for fucoidan extraction to be used 










CHAPTER I: EXTRACTION AND CHEMICAL 





                                                                                                           
                      
                                                                              
                          






Define the Problem  
Side effects of several drugs in                 
treating Oxidative stress 
and oxidative stress related diseases                                
such as NAFLD                                                                         
Research Questions  
Replace synthetic drugs with natural derived 
compounds (Fucoidan polysaccharide).   
Does the terrestrial plant F. hermonis 
contains FUC? 
Determine the difference in structure of 







Since ancient times, plants have been used as a medical source for treating human diseases. 
Nowadays, the search for natural compounds displaying therapeutic efficacy with less toxicity 
and side effects than synthetic drugs is still of great interest. A huge amount of phytochemicals 
are currently being studied for their potential benefits against the major threats to human health, 
i. e. non-communicable diseases including cardiovascular disorders, cancer, autoimmunity, 
neurodegenerative diseases, as well as metabolic impairments related to insulin resistance and 
liver disorders, such as Non-Alcoholic Fatty Liver Disease (NAFLD). The search for natural 
bioactive compounds has been focused on renewable resources such as marine algal seaweeds 
as they contain a wide range of phytochemicals such as pigments, vitamins, minerals, lipids, 
proteins, and polysaccharides  . Seaweeds are classified based on their pigmentation into green, 
red, and brown algae. In this study, we will give a brief explanation on different brown algal 
polysaccharides such as “Alginate”, “Laminarin”, but focus mainly on “FUCOIDAN”. 
Fucoidan, an example of marine phytochemicals, is a fucose-rich sulfated polysaccharide 
abundant in the cell wall of marine brown algae that gained a great interest in research due to its 
several biological activities including anti-viral, anti-cancer, antioxidant, anti-inflammatory, 
anti-diabetic effects.   
In this study, fucoidan was extracted from the marine brown algae “Cystoseira compressa” and 
for the first time from the terrestrial plant, “Ferula hermonis” and chemically characterized by 
studying the structural features. Then together with a previously purified fucoidan from 
“Eucalyptus globulus” were investigated for more detailed chemical composition. Our results 
indicated that the yield of fucoidan purified C. compressa and F. hermonis was 3.6 % and 3.07%, 
respectively. Furthermore, the chemical structure analysis confirmed the presence of functional 
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                     TRADITIONAL MEDICINE 
TRADITIONAL MEDICINE is defined as “the sum total of the knowledge, skills, and 
practices based on the theories, beliefs, and experiences indigenous to different cultures, 
whether explicable or not, used in the maintenance of health, as well as in the prevention, 
diagnosis, improvement or treatment of physical and mental illnesses” (C.T. Che et al., 2017).  
Between 350,000 and almost half a million of plant species have been used as a source for the 
cure of human diseases, nobody knows exactly where and when the medicinal plants were used 
for the first time. The purpose was and still to improve overall health; in the beginning, plants 
were used to treat illnesses or even simply to feel better distinguishing useful plants with 
beneficial effects and then their use has been gradually refined over the generations to be known 
as traditional medicine. 
Previously, the knowledge about medicinal plants was transmitted orally before the written texts. 
The first written text about the use of medicinal plants was 4000 years ago in a clay small board 
in the Sumerian culture, which would be equivalent to the current Iraq territory. 
All civilizations have developed this form of medicine that varies among countries based on 
their own habitat, culture, history, and personal attitudes. There are even authors who claim that 
this transmitted knowledge is the origin of medicine and pharmacy.  
Until the 18th century, all the knowledge related to traditional medicine was summarized in the 
species of the used plants, their therapeutic properties, effects on human health and their method 
of treatment, while the active compound was unknown. Medicinal plants have been used to treat 
several diseases; for example, chamomile flower is commonly used for anxiety and relaxation, 
ginger is used to ease nausea, tanacetum parthenium flower known as feverfew where it was 
traditionally used to treat fevers, and garlic that is used for lowering cholesterol and blood 
pressure. Until that time, the Canon of Medicine written by the Persian physician and scientist 
Avicenna (Ibn Sina) was used as a reference.  
The origin of modern science, specifical improvement of chemical analysis and microscopic 
applications made a significant scientific transformation where it was possible to isolate the 
active principles of medical plants. Since then, these active compounds have been identified and 
used as a raw material in pharmaceutical medicine industry such as phenolic acids, 
oligosaccharides, polysaccharides, flavonoids, terpenoids and alkaloids (Thakur et al., 2020). 
Today, due to the increased demand of herbal products, hundreds of higher plants are cultivated 
worldwide to obtain useful substances in medicine and pharmacy. Yet, due to the high cost of 
modern medicine with synthetic origin many countries of the underdeveloped world continue to 






Traditional Medicine Drawbacks  
It should be noticed that applications related to traditional medicine must be sufficiently 
researched due to two major drawbacks. 
• The use of medicinal plants without sanitary control and without thinking about the 
possible harmful aspects for health. Some plants may have dangerous active principles. 
For example, the green seeds of Bitter melon (Momordica charantia) used to cure fever 
and in cases of malaria are very toxic as they can cause a sharp drop in blood sugar and 
induce a patient’s coma (hypoglycemic coma). 




Global Traditional Medicine Evolution 
Plants have been and still considered a significant source of pharmaceutical drugs. According 
to a recent study that analyzed a big number of publications, several categories have been 
developed based on the number of published articles, research area, countries, and keywords 
(Manzano et al., 2020).  
➢ Temporal Evolution of Medicinal Plants 
Since 1960, more than 100,000 articles related to medicinal plants have been published. This 
period was divided into three intervals based on the trend increase of publications.  As shown in 
figure 1.  
• From 1960 till 2001, the increase was continuous with just 1300 published studies. 
• From 2001 till 2011, this trend increases faster with the maximum number of 
publications (6200). 






Figure 1: Worldwide temporal evolution of medical plants publications. 
 
➢ Traditional Medicine Scientific Categories 
Published studies related to medicinal plants can be divided based on the interested scientific 
major, for example most of the studies have been carried out in the Pharmacology, 
Toxicology and Pharmaceutics. Followed by other categories such as: Medicine, 
Biochemistry, Genetics and Molecular Biology, Agricultural and Biological Sciences, 
Chemistry, Immunology and Microbiology, Environmental Science, Chemical Engineering, 
and other categories (Nursing, Neuroscience, Earth and Planetary sciences, materials 
science, and Health Professions)  
 
➢ Medicinal Plants Publications by Countries  
Countries involved in traditional medicine research can be arranged in three groups based 
on the annual number of publications.  
 
Figure 2: Diagram showing the classification of countries into three groups based on number of    
publications related to traditional medicine.  
Group 1 (800 and 
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Figure 3: Cloud word of keywords related to medical plants publications. If keywords are extracted 
from the total number of publications, an overview can be made of the most used keywords in relation 
to traditional medicine. The most indexed terms are human, non-human, unclassified drugs, plant 




                          MARINE RESOURCES: ALGAE 
 
Recently, interests have been focused on renewable natural sources, which shifted the search 
from terrestrial plants to marine resources such as sponge, bacteria, cyanobacteria, fungi, and 
algae. Algae are considered as a huge marine resource, defined as simple photosynthetic 
chlorophyll containing organisms, with great diversity in terms of morphological, structural, 
ecological, chemical, and physiological traits.  
 
ALGAL CLASSIFICATION  
Algae are divided into two main groups: 
➢ Microalgae: are microscopic algae found in the freshwater and marine systems. They 
are unicellular organisms that exist individually or in groups ranging from a few 
micrometers (μm) to a few hundred micrometers. Microalgae do not have roots, stems, 
or leaves. They can perform photosynthesis producing approximately half of the 
atmospheric oxygen, used as bioactive compounds, food colorants pigments, cosmetics, 
and biofuel production (Priyadarshani et al., 2012).  





                            
 
 
➢ Macroalgae: known as seaweeds, are macroscopic multicellular organisms that range 
from few millimeters to 30 meters in size. For example, the brown algae “giant kelp” is 
the largest seaweed (30 meters). Seaweeds also can perform photosynthesis, used as 
human foods, cosmetics, fertilizers, and for the purification of chemicals with medicinal 
and industrial uses. In this research study, we therapeutic activities of macroalgae.  
 
            
 
                                                   SEAWEEDS 
 
Seaweeds Structure and Divisions  
Seaweeds are still categorized as plants, but different in structure; they lack roots and have 
instead holdfasts for attachment rather than water and nutrient absorption, they have stripe as a 
stem used for support. Moreover, the leaves are called blades that function in providing a surface 
for sunlight absorption. Many Seaweeds have hollow, gas-filled structures called floats, such 
structures help in photosynthesis and energy absorption. The whole seaweed body refers as 
thallus (Mouritsen et al., 2013).  
Furthermore, they are divided into three groups (El Gamal et al., 2009): 
1. Chlorophyta,  are green algae due to the presence of chlorophyll a and b; about 1200 
species. 
      Examples: chlorella, Ulva lactuca, and Aegagropila linnaei.  
2. Phaeophyta; contain around 1750 species, brown in color results due to the dominance 
of xanthophyll pigments and fucoxanthin over chlorophyll pigments, and the red algae. 









3. Rhodophyta:  about 6000 species; chlorophyll pigments are masked by other pigments 
such as phycoerythrin and phycothcyanin leading to red color dominance. 
      Examples: Gigartinales, Nemaliales, and Gracilaria.  
 





Seaweeds: A Brief History 
Human and seaweed interaction seems to date back to many thousands of years and even before 
Christ.  Some researchers suggest that seaweed has been used since 2700 BC in China. One of 
the oldest recorded writings in Iceland, refers to 961 BC related to regulations about coastal 
property rights with respect to sea vegetables. In 600 BC, Sze Teu wrote a book about seaweeds 
in China, followed by a book written by Chi Han in 300 BC related also to seaweeds. 100 BC, 
Greeks have used seaweeds to fed animals. In addition to the fact that some red algae were used 
since pre-Christian times as a source of medicine to treat parasitic worms. 
2000 years ago, people from Japan have used seaweeds as a supportive food in their diet, to 
become later an everyday food where after 800 years it was reported at least six types of 
seaweeds used in everyday cooking. Then seaweeds gained much more interest as food and 
fertilizer; in Ireland, algae collection started 800 years ago (Buschmann et al., 2017).  
 
Global Seaweed Production  
Despite their historical applications, only 70 years ago seaweed farming technology has been 
significantly developed mainly in Asia, then in America  and Europe. According to the latest 
data adapted from Food and Agriculture Organization, in 2016 seaweed production reached 31.2 
million tons (fresh weight). 96.5% of this weight was produced in aquaculture while just 3.5% 
was harvested from natural populations. The top seaweed-producing countries are Asian as we 
previously said: China, Indonesia, Philippines, Korea, and Japan. The demand of seaweed as 
food has spread, which lead to commercial farming projects for selected brown and red algae in 
many countries such as the USA, Canada, Brazil, France, and parts of  Africa.  





In 2000, world seaweed production reached around 10 million tons, as it increases greatly to 
reach 31.2 million tons after 16 years. This means that the global annual seaweed production 
does not stop growing (Poza et al., 2020).  
 
Industrial Seaweed Applications  
Seaweeds have many applications in several fields. They have been considered as suitable 
fertilizers and soil conditioners thousands of years ago, especially the large brown seaweeds. 
Their effectiveness as fertilizer is attributed to the presence of trace elements while the large 
amounts of insoluble carbohydrates improve aeration and soil structure which explains their 
application as soil conditioners.  
At the end of the 19th century and beginning of 20th-century seaweeds bath was widely spread 
in which they were used as a treatment for arthritis, rheumatism and other aches and pains. 
Moreover, seaweed powder has been involved in synthesizing body care products and other 
various cosmetic applications.  
Seaweeds, specifically the red algae Gelidium genus is considered the main source of the 
polysaccharide agar, a natural vegetable gelatin counterpart used as a thickening agent and 
most important as a solid substrate for the growth of bacteria and fungi in a microbiological 
laboratory. Agar has been produced by most of the countries such as China, France, India, 
Indonesia,  Japan, Madagascar, Mexico, Morocco, Namibia, Argentina, Canada, Russia, South 
Africa, Spain, Thailand, and the USA (Kılınç et al., 2013). 
 
 
Seaweeds Nutritional Value  
Sze Teu wrote in his book "Some algae are a delicacy fit for the most honored  guests, even  
for the  King  himself." 
Sixty-six percent of seaweed applications are used directly in food (Rhodophyta: 79; 
Phaeophyta: 38; Chlorophyta: 28 species). The importance of seaweeds in the diet is 
attributed to minerals (sodium, calcium, magnesium, potassium, chlorine, sulfur, phosphorus), 
vitamin, protein, carbohydrates, and fiber content present at different concentrations in 
different species. Generally, protein contents is higher in green and red seaweeds (10–47 of 
dry weight—DW) than those in brown seaweeds (5–24% DW); lipids from 0.79% to 7.87% 
dry matter and dietary fiber proportion ranging from  36% to 60% of its dry matter. The most 
edible  seaweeds are known as Nori, Kombu, Wakame, laverbread and Sea lettuce.  
In the early 1980s, there has been a growing interest in functional food, simply defined as 
“processed foods having disease-preventing and/or health-promoting benefits in addition to 





functional food usually produced as food supplements, rather than whole foods and are 
marketed as tablets and pills to provide health benefits. (Peṅalver et al., 2020)  
 
 Table 1: Source and nutritional value of the most known edible seaweeds 
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Marine Seaweeds Bioactive compounds  
Besides their traditional use in Oriental cuisine and their unique nutritional properties, algae 
have recently gained great research interests based on their potential role as functional food or 
nutraceuticals. This is mainly due to the high presence of several bioactive compounds produced 





phytochemicals with beneficial effects against diseases. This wide range of biological 
compounds includes pigments, lipids, vitamins, minerals, proteins, and carbohydrates (most 
importantly polysaccharides).  
➢ PIGMENTS:  marine seaweed pigments are divided into three types:  chlorophylls, 
carotenoids and phycoerythrins.  Chlorophylls are greenish fat-soluble pigments found 
in terrestrial plants, algae, and cyanobacteria in which they play a key role in the 
photosynthesis  phenomenon. Carotenoids are also called tetraterpenoids, are yellow, 
red, and orange pigments. Marine algal carotenoids include carotenes, fucoxanthin (the 
most abundant carotenoids), lycopene, astaxanthin, zeaxanthin and neoxanthin.  
Phycoerythrin is a red protein-pigment complex. These pigments have biological 
potentials, nutritional value and used as food colorants with antioxidant, anti-
inflammatory, anticancer, antidiabetic, antiangiogenic and immunomodulatory 
properties.  
➢ LIPIDS:  usually lipid content of marine seaweeds does not exceed 5 % of their dry 
weight, varies among species, even within the same species according to several 
geographical conditions,  climatic factors, and seasonal variations. Seaweeds fatty acid 
profile contains a wide range of polyunsaturated fatty acids (PUFAs). In addition to the 
sterols mainly represented by fucosterol, clionasterol and cholesterol with important 
nutritional and biological properties, such as anticancer, antioxidant, anti-obesity, 
antitumoral, antiviral, and are effective against cardiovascular diseases.  
➢ PROTEINS:  marine seaweeds are considered a good source of most amino acids such 
as proline, alanine, glycine, arginine, and especially aspartic and glutamic acids. This is 
due to the wide range of proteins that can vary from 5% to 47% of their dry weight (w/w) 
depending on several factors as we mentioned above. Generally, protein content in  green 
and red is higher compared to brown algae, and proteins exhibit a large spectrum of 
bioactivities.  
➢ VITAMINS and MINERALS: seaweeds are wealthy sources for vitamins and minerals. 
Both water soluble (such as  vitamins B, and C) and lipophilic vitamins ( vitamins A, D, 
E, and carotenoids ). Furthermore, algal seaweeds contain significant amounts of macro-
elements (Ca, K, P, Na, Mg,  and Fe) and trace of elements (Pb, Cu, Zn, Sc, Sd, As, Sr 
and Cr). 
➢ CARBOHYDRATES: marine macroalgae are a good source of carbohydrates that varies 
from 5 to 75% of their dry weight and consist mainly of polysaccharides with few 
amounts of disaccharides and monosaccharides. Algal  Polysaccharides can be found in 
different forms sulfated and non-sulfated depending on different species. Green marine 
algae are rich in ulvans, red seaweeds contain carrageenans, agars, and sulfated 
galactans, while brown macroalgae are characterized by the presence of alginates 










Supplementary Box 1: Seaweed cultivation 
Seaweed cultivation is becoming an increasingly competitive candidate for the increased 
demand on seaweeds due to their different uses such as food, industrial, cosmetical, and 
medicinal applications.….Seaweed production reached 30 million tons by 2016, which 
as mainly produced by Asian nations (China, Japan, Korea, and the Philippines). The 
most cultivated species are the brown algae Laminaria japonica and Undaria 
pinnatifida, the red algae Porphyra, Eucheuma, Kappaphycus and Gracilaria and the 




BROWN ALGAL POLYSACCHARIDES 
 
Brown algae include about 250 genera for a total of over 1500 species that exhibit a great variety 
of shapes and sizes. They can be abundantly harvested, characterized by a high productivity rate 
and some species (such as Hijikia fusiforme, Laminaria japonica, etc.); cultivated on a large 
scale to be used as food or food additives. Brown algae prefer growing in cold water, able to 
grow underwater depth of 30-50 meters but mostly present in the intertidal and upper sublittoral 
zones of the oceans. 
 
Brown Algal Polysaccharides  
As for plant cells, algal cells are surrounded by a polysaccharide-rich cell wall. However, brown 
algal polysaccharide (BAPs) exhibit some unique structural features, such as the presence of 
sulfate, fucose, and uronic acid, that differentiate them from the polysaccharides of terrestrial 
plants. This seems to be related to marine algae adaptation to a high salt environment: as an 
example, sulfated polysaccharides facilitate water retention in extracellular matrices, thus 
preventing desiccation in low tide conditions. The most represented sulfated polysaccharide in 
brown algae is FUC, but major BAPs also include alginate (ALG) and laminarin  (LAM). 
Structural BAPs diversity can be appreciated among different algal species or even within the 
same species, notably depending on the environment, seasonal variations, and reproductive 
status of the organism. Here we will give a brief explanation about ALG and LAM, then a 





• ALGINATE: is a negatively charged polysaccharide isolated from the brown algal cell 
wall, as well as from some bacterial strains. ALG is a linear biopolymer that consists of 
1,4-linked β-D-mannuronic acid (M) and 1,4 α-L-guluronic acid (G) residues arranged 
in homogenous (GG/MM) or heterogeneous (MG) block-like patterns. The well-known 
physical properties of ALG, such as viscosity and gel-forming, and its biological 
potentials are determined by molecular weight, M/G ratio and distribution, temperature, 
environmental pH, and extraction method. The non-toxic and biodegradable ALG has 
gained great importance due to its several applications in the food industry, as gelling 
and a thickening agent, in dermatological and cosmetic preparations, and in the textile 
industry. Furthermore, ALG is pharmaceutically used due to its antibacterial, 
antidiabetic, antitumor, and antioxidant potentials. 
 
• LAMINARIN: LAM is a low molecular weight polysaccharide (approximately 5 kDa), 
composed of (1,3)-b-D-glucan with β (1,6) branches and showing a variety of bio-
functional properties. LAM is a storage glucan used as a carbohydrate food reserve (El 
Rashed et al., 2020).  
 
• FUCOIDAN: Explained below in detail. 
 




In 1913, FUC was extracted for the first time from a species of brown algae, such as Fucus 
vesiculosus and Ascophyllum nodosum by Kylin et al. FUC is negatively charged, a highly 
hygroscopic and water-soluble polysaccharide. Recently the literature about the potential clinical 
applications of FUC is extremely rich, due to its wide spectrum of biological activities ranging 
from anticoagulant/antithrombotic, antiviral, immune potentiating, angiogenic, anticancer, 
antidiabetic, antioxidant, and anti-inflammatory.  
 
Sources of Fucoidan   
FUC polysaccharide is very abundant in the cell wall of Phaeophyta (mainly L. digitata, A. 
nodosum, Macrocystis pyrifera and F. vesiculosus), but also found in marine invertebrates, such 
as in the jelly coat from sea urchin eggs and in the sea cucumber body wall. More recently, FUC 
has been isolated also in terrestrial plants such as Eucalyptus globulus (Pomin et al., 2012) 






Structure of Fucoidan 
FUC is a fucose-rich sulfated polysaccharide purified mainly from the brown algal extracellular 
matrix. FUC is characterized by the presence of fucose, sulfate groups and one or more 
monosaccharides (such as xylose, mannose, galactose, rhamnose, arabinose and glucose), 
glucuronic acid and acetyl groups in some species. FUC has two types of fucose backbone, either 
of α-(1 – 3)-linked fucose repeated units or α-(1 – 3)- and α-(1,4)-alternating linked fucose 
residues. The main commercially available form is extracted from Fucus vesiculosus and is 





Figure 4: Chemical structure of brown algal polysaccharides: fucoidan, alginate, and laminarin 











Structural-Biological Diversity  
FUC structure is highly variable depending on several factors such as extraction method, 
variation in a season of collection, geographical location, population age and species type. The 
structural difference is characterized also by variation in monosaccharide composition, sulfate 
content, sugar binding residues and molecular weight, all leading to different biological 
potentials.   
The anti-tumor activity of two portions of FUC extracted from Undaria pinnatifida with 
different molecular weights (5100 and 490 kDa) with no significant difference in sulfate content, 
results showed that the anti-tumor activity of low molecular weight FUC was higher by two 
folds compared to the other FUC extract. Increased sulfate content usually yields an increased 
biological activity (Wang et al., 2019).  
 
Fucoidan Bioavailability, Absorption and Pharmacokinetics.  
In the last decade, several studies have investigated the biological activities of FUC; while only 
a few articles have reported FUC pharmacokinetic, intestinal absorption, tissue distribution, and 
excretion. Due to the high molecular weight and great structural diversity, several difficulties 
have been associated with understanding the uptake and fate of FUC.  
In 2015, Nagamine et al. investigated intestinal absorption of FUC extracted from the brown 
seaweed, Cladosiphon okamuranus using human colorectal adenocarcinoma Caco-2 cell line as 
an in vitro model and in vivo Wistar rats. Results indicated that FUC transport across Caco-2 
increased in a dose dependent manner to reach the maximum after a specific time (1 hour) and 
then decreased. This saturability of FUC transportation does not occur in simple diffusion, which 
suggests FUC absorption via transporter or pinocytosis. Furthermore, immunohistochemical and 
ELISA methods revealed the accumulation of FUC in jejunal epithelial cells, mononuclear cells 
in the jejunal lamina propria, Kupffer and sinusoidal non-parenchymal cells in the liver 
(Nagamine et al., 2015).   
Studying pharmacokinetics and tissue distribution of FUC is crucial for drug development as for 
understanding biological activities. FUC concentration purified from F. vesiculosus was 
analyzed in serum and tissues based on measuring anti-activated factor X (anti-Xa) activity.  The 
highest  concentration of FUC was found in kidneys followed by the spleen and liver, while the 
lowest was detected in plasma (Pozharitskaya et al., 2018).  
Recently, a new technique based on fluorescence detection was used to provide  better 
knowledge about the mechanism of FUC absorption. FUC purchased from sigma aldrish (F. 





traverse Caco-2 monolayer cells and their tissue distribution after injection in mice. Results 
confirmed FITC-fucoidan transport across Caco-2 cells and their targeted accumulation in the 
kidney and liver (Bai et al., 2020).  
Furthermore, there are  two clinical trials focusing on FUC; one on the biodistribution and 
tolerance of Fucoidan where  healthy individuals or volunteers are involved in integrating FUC 
within their diet followed by tests that involve the biodistribution and safety  of FUC while the 
other FUC is added to the chemotherapeutic treatment of patients with stage III-IV non-small 
cell lung cancer. This illustrates the importance of more studies to be performed related to FUC 
(Irhimeh et al., 2005). 
 
Supplementary box 2:  Fucoidan Pharmacokinetics  
Paracellular transport is defined as the transport of substances across an epithelium by 
passing through the intercellular space between the cells, while transcellular transport 
refers to the transfer of substances through the cell, passing through both the apical 
membrane and basolateral membrane. 
Pinocytosis is a type of endocytosis where small particles suspended in extracellular 
fluid enter the cell through cellular membrane invagination.  
Plasma anti-activated factor X (anti-Xa) activity assay  : Factor Xa is one of the proteins 
involved in blood clot formation. Anti-Xa activity  is used to measure plasma heparin 
levels and to monitor anticoagulant therapy. This assay is based on the inhibition of 
activated factor X (FXa) by Antithrombin (AT) in the presence of heparin as free Xa 
measured by a chromogenic Xa substrate. FUC shows certain structural similarities to 
heparin due to their polysaccharide nature and high negative charge density due to 
sulfation. In addition to the anti-coagulant effects of FUC. Thus, anti-Xa activity was 
used for the characterization of the pharmacokinetics and tissue distribution of fucoidan 
in plasma and tissues. 
 
 
Biological Activities of Fucoidan  
Anti-cancer:  
Cancer is defined as a multifaceted process as several oncogene mutations in a group of cells 
end in an uncontrolled proliferation leading to tumor formation and spreading. It is a major cause 
of global mortality as the most used therapy “chemotherapy” still has side effects in addition to 
multidrug resistance. Thus, natural anti-tumor products with low toxicity are importantly 
required. FUC is a polysaccharide with anti-tumor potentials against a wide range of cancers. 
FUC purified from C. okamuranus was suggested to cause cell cycle arrest at G0/G1 phase in 
hepatocarcinoma cells (Sibusiso et al., 2019). Another study on colon cancer showed that FUC 
purchased from  F. vesiculosus inhibits tumor cell proliferation and induces apoptosis (Wang et 





pinnatifida using human prostate cancer cells, where results showed that FUC induced apoptosis 
by activating both extrinsic and extrinsic pathways (Boo et al.,2013).  Some clinical studies 
focused on combining FUC with other anti-cancer agents and results indicate a promising 
potential of FUC as a therapeutic agent (Sibusiso et al., 2019). 
Anti-viral: 
FUC has been shown to alleviate some viral diseases symptoms and shorten the disease period, 
thus FUC can be used as an antiviral agent with low toxicity and resistance. Previous studies 
show that FUC inhibits the human immunodeficiency virus, herpes simplex virus, hepatitis B 
Virus, human cytomegalovirus, and influenza virus. The mechanism of antiviral activity of FUC 
is to inhibit virus adsorption onto host cells by interacting to the positively charged viral 
glycoprotein located on the envelope that is crucial for virus attachment (Wang et al., 2019).  
 
Antioxidant:  
Briefly, reactive oxygen species (ROS), a group of oxygen or nitrogen containing intermediates, 
unstable molecules that can easily react with cellular components and cause damage to DNA, 
RNA, and proteins. ROS types, production, effect, and elimination will be detailed in the next 
chapter. Oxidative stress OS resulted from high levels of ROS is common in a wide range of 
diseases such as neurodegenerative diseases , coronary heart disease, , diabetes, atherosclerosis, 
inflammatory diseases, and aging-related diseases. Thus, research focus on an intense 
identification of non-toxic antioxidant compounds. FUC is a well-known antioxidant compound 
acting as a ROS scavenger.  FUC purified from Laminaria japonica and Undaria pinnatifida 
has been shown to exhibit Significant  anti-oxidative properties (Wang et al., 2019).  
 
Anti-inflammatory:  
The inflammatory response is explained as a reflection to numerous inflammatory factors, that 
when correctly regulated mediates the body’s resistance to disease but can also cause tissue 
damage in case of overactivation. Inflammation is a common reaction in several diseases such 
as atherosclerosis, diabetes, neurodegenerative diseases, autoimmune diseases, liver diseases 
and  those related to aging.  
Previous studies demonstrated that FUC polysaccharide regulates inflammatory response in 
which FUC treatment inhibits nitric oxide (NO), intestinal inflammation, and leukocyte 
migration. On the other side, FUC synergistically enhanced the activity of anti-inflammatory 
drugs (Wang et al., 2019). 
 
Prebiotics:  
Dietary prebiotics were first identified by Marcel Roberfroid in 1995 as compounds that induce 
the growth and activity have been used as functional food ingredients with health benefits due 
to the presence of indigestible dietary polysaccharides that pass undigested through the upper 
part of the gastrointestinal tract. The main source of polysaccharide in human’s diet  originate 





fact that around 45% of the world’s land surface is considered dry lands and lack of water is 
leading to 12 million hectares to be degraded yearly; recent studies suggest that in the next 
decades algae production will increase to replace or supplement plant food intake of terrestrial 
origin. Polysaccharides and oligosaccharides derived from marine origin have shown the 
potential to modulate intestinal metabolism, inhibit pathogen adhesion and invasion, stimulate 
the growth and activity of beneficial bacteria, and treat inflammatory bowel disease 
(Santamarina et al., 2020).   
Previous in vivo studies showed that FUC (purified from A. nodosum) administration resulted 
in microbiota diversity increasing the beneficial Lactobacillus strain, which produce lactic acid 
preventing harmful bacteria colonization and a decrease in serum levels of lipopolysaccharide-
binding protein (Shang et al., 2016). Furthermore, FUC obtained from Laminaria japonica 
decrease the pathogenic bacterial Enterobacter species, increase Lactobacillus, increase lactic 
acid and short-chain fatty acids (SCFA) (Kong et al., 2016).   
Metabolic Syndrome Treatment: Metabolic syndrome (MS) refers to a cluster of interrelated 
factors and conditions leading to a pathophysiological state considered as a common feature of 
cardiovascular, cerebrovascular disease, insulin resistance, hypertension, and diabetes. MetS can 
be described also as a state in which proteins, fats, carbohydrates, and other substances in the 
body are metabolically disordered. Previous studies showed that FUC is attractive for improving 
and treating obesity in terms of lipid lowering effects that will be explained in detail within 
upcoming chapters (Wang et al., 2019).  
 
 
Fucoidan Extraction Principle   
Polysaccharides extraction and purification from algal cell wall is a complex and challenging  
process especially in the presence of a mixture of biopolymers. Fucoidan extraction involves 
five general steps: 
1. The first step is considered as pre-treatment in which collected algae are dried and milled 
to have a higher surface-to-volume ratio; homogenous constant mass is obtained.   
2. Lipids, terpenes, phenols, and pigments removal.  
3.  Crude FUC extraction by treating algal raw material different solvents (water, acidic or 
alkaline solution). This step may be repeated several times for a higher extraction yield.  
4.  FUC purification and its separation from other co-extracted contaminants.  
5. The last step in extraction is known as dialysis, a process based on the utilization of 
different molecular weight cut-off membranes to separate FUC from smaller compounds 
depending on the high molecular weight of fucoidans, also to separate low molecular 







Despite the difference in extraction method and the solved used, the main aim is to obtain an 
increased yield of FUC with high quality. Acidic solution extraction avoids alginic acid release 
with FUC and gives a better yield when compare to water, while water extraction maintains the 
stability and overall charge of FUC and alkaline solvent extraction usually co-extract alginic 




Fucoidan Quality and Chemical Characterization  
 
❖ Spectrophotometrical Analysis 
As above mentioned, structural and compositional differences in the purified sulfated 
polysaccharide result in a wide diversity of biological activities. This means that sugar, sulfate, 
and protein content determination are crucial for predicting FUC composition. Sugar, sulfate, 
and protein content were determined by colorimetric assays based on the utilization of standard 
curves. Sulfate and protein content were assessed spectrophotometrically by a simple and rapid 
assay based on their precipitation in the presence of agarose reagent and trichloroacetic acid 
(TCA).  
Sugar content is analyzed by the most reliable and easiest colorimetric assay, based on the 
principle of sugar oxidation in the presence of sulfuric acid into a product that reacts with phenol. 
The final product light absorbance is determined by an ultraviolet spectrophotometer which is 




FUC polysaccharides are characterized by their complex chemical structure, which means that 
several spectrometric methods have been used to elucidate FUC structural features such as the 
functional groups and the position of the glycosidic bond.  
 
 Fourier Transform Infrared spectroscopy FTIR: It is a technique for the identification of 
organic inorganic and polymeric material based on the absorption, emission of an infrared 
spectrum in the range of 400 and 4000 cm−1. In this method, the mathematical process 
(Fourier transform) is utilized to translate the raw material into a spectrum that is used to 
identify specific functional molecular groups in the sample as compared to spectrum data in 
the automated software of spectroscopy. FTIR is useful also to identify the characteristics of 
unknown samples and detecting additives or contaminants in a material (Titus et al., 2019). 
Previous studies showed that the preliminary identification of FUC functional groups is 
usually performed by studying the FTIR spectrum of the sample, in which typical IR bands 





monosaccharides, C-H, C-O-S of sulfate ester groups, S=O stretching, O-C-O and C-O-C of 
glycosidic linkage.   
 
 Nuclear Magnetic Resonance Spectroscopy NMR: It is the most significant analytical tool 
used in chemical research to investigate the dynamics and structural features of a compound 
in a solution or solid state. NMR is associated with energy absorption and emission. The 
theory behind this technique is based on the absorption of electromagnetic field by nuclei of 
the atoms. The NMR spectrum is a plot that measures relative resonance intensity as a 
function of chemical shifts in parts per million (ppm). Chemical shift is defined as the 
difference in ppm  between the resonance frequency of the sample and a reference.  
 
 
➢ Proton NMR (1H NMR) is the application of NMR with respect to hydrogen atoms 
within the molecule to determine the structure.  
➢ Carbon NMR (13C NMR) is analogous to 1H NMR, but instead applied with respect to 
carbon atoms, it gives information about the carbon skeleton and not just the proton 
attached to it. (Diehl et al., 2008) 
 
Both forms of NMR spectroscopy have been widely used to study the structure of fucoidan in 




















In this study we aimed to extract FUC from the brown marine algae; Cystoseira compressa, and 
the terrestrial plant; Ferula hermonis. The purified polysaccharides were chemically 
characterized by FTIR and NMR techniques. Previously Kanaan et al. have extracted FUC for 
the first time from the terrestrial plant “Eucalyptus globulus”. Sugar, sulfate, and protein content 
were determined in FUC extracted from the three species.  
The difference in conditions between marine and terrestrial environments are important factors 
that may contribute to the formation of a wide scale of chemical compounds. Marine algae 
contain polysaccharides that have a different composition, substitutions, and linkage types than 
terrestrial polysaccharides, and some are unique for algal species such as sulfated 
polysaccharides.  Brown seaweeds are considered as the main source of FUC polysaccharide, 
but recently FUC was identified in the terrestrial plant (Zheng et al., 2020) (Haddad et al., 2017).  
Briefly, we explained below about the three species.  
 
CYSTOSEIRA COMPRESSA 
C. compressa is a brown algae species from Cystoseira genus, belongs to the family of 
Sargassaceae in the order of Fucales. Cystoseira have highly differentiated basal and apical 
regions with floating air-vesicles like structures. This genus provides an essential habitat for 
several epiphytes, fish, and invertebrates; it is mostly found in the Mediterranean, Indian,  and 
Pacific Oceans.Cystoseira genus consists of 293 species including C. compressa. The first 
publication related to C. compressa was in 1975 by Gerloff and Nizamuddin; C. compressa was 
first identified in the Adriatic Sea which is the arm of the Mediterranean Sea, lying between the 
Italian and Balkan peninsulas. (Gerloff et al., 1975).  
Morphological variations of C. compressa is explained by  thallus change in terms of size and 
appearance in relation to seasonal and environmental factors especially wave exposure 
variations. The vegetative development is observed in spring- presenting  fresh algal material 
where thalli reach their maximum height and physiological activity in June; while in late 
summer, specifically August almost loses all upright branches (Falace et al., 2005).   
In 2014, Kanaan et al. investigated the diversity of seaweeds growing on the Lebanese coasts. 
C. compressa was identified in three checked zones out of eight: Tyre, Barbara, and Naqoura 
(Kanaan et l., 2014). 
Previous studies showed that C. compressa aqueous extracts have good anti-microbial, 
antioxidant, anti-inflammatory and anti-proliferative activities against HCT and MCF-7 cell 
lines (Mhadhebi et al., 2014). In 2017, Ammar et al. extracted alginates from C. compressa that 
showed gastroprotective effect and inhibited gastric lesions. Moreover, FUCs isolated from C. 





decrease of gastric mucosal damage. Moreover, acetone extract of C. compressa was tested for 
its anti-microbial and cytotoxic properties (Kosanić M et al., 2015). In a recent study, C. 
compressa methanol extract showed high antioxidant potentials, and tested for its anti-diabetic 
activity as it exhibits a high α-glucosidase and pancreatic lipase inhibition rates (Çelenk et al., 
2020).    
    
    












Ferula hermonis, a small flowering plant that belongs to the Apiaceae family. It is commonly 
known as “Shirsh El Zallouh”, endemic in Lebanon, Syria, Turkey, and Jordan.  Roots are 
usually harvested from August to October, then extracted to be traditionally used in order to 
enhance sexual behavior, treat infertility and menopausal disturbances, in which it is commonly 
known as or “Lebanese Viagra” (Sattar et al., 2017). This plant is sold in many herbal shops in 
Lebanon, Syria, and other Arabic countries. 
Moreover, it has been shown that F. hermonis exerts anti-bacterial, anti-inflammatory, anti-
diabetic, hypolipidemic, and hepatoprotective effects. In 2008, Elouzi et al. investigated the 
cytotoxic effect of petroleum ether, ethyl acetate, and methanol F. hermonis extract against 
stomach cancer cell line. F. hermonis essential oil components were shown to exhibit strong 
anti-fungal activity particularly against the dermatophyte Tricophyton mentagrophytes (Al-
Ja’fari et al., 2013). Another in vivo study demonstrated the antioxidant and antidiabetic effects 
of F. hermonis by reducing blood glucose concentration and body weight, as inducing  catalase 
serum levels (Raafat et al., 2015).  
These biological activities are related to the presence of a wide range of active compounds such 
as sulfur-containing compounds, sesquiterpenes, coumarins, ferutinin, α-pinene, camphene and 
carvacrol, as well as  vitamins (A and E) and some minerals (Sattar et al., 2017). According to 
the chemical composition reported by Abdel-Kader et al. (2011), F. hermonis roots contain 
38.38 % carbohydrates, 8.33 % lipids and 3.48 % proteins; however, to our knowledge, no 
investigation has been conducted on the water-soluble polysaccharide fractions. 
 












E. globulus was first mentioned in 1800 by Jacques Labillardière in his book “ Relation du 
Voyage à la Recherche de la Pérouse” where he described specimens collected in 1792 at 
Recherche Bay located on the extreme south-eastern corner of Tasmania, Australia (La 
Billardière, 1800). It belongs to the family of Myrtaceae that include around 140 genera and 
3800 species distributed in tropical and subtropical regions of the world. Among these genera, 
Eucalyptus is one of the world’s important and most cultivated genera.  
E. globulus is a tall aromatic tree, also known as the blue gum due to the green color of its foliage 
that remains through more than one growing seasons. This terrestrial tree has a height average 
of 45 meters (m), but under some conditions can grow as tall as 90-100 m. E. globulus green 
leaves are arranged in opposite pairs, with flower buds arranged singly or in groups of three or 
seven in leaf axis. Despite the native distribution of E. globulus in forests located in New South 
Wales, Victoria, and Tasmania; blue gum was planted in several countries with Mediterranean-
type climate such as Algeria, Lebanon, and Italy where it rapidly grows (Hillis et al., 1984).    
E. globulus flowers are a good source for honey production while leaves were used as herbal 
tea, in addition to essential oil extraction as this species is considered the primary source of 
global eucalyptus oil production; essential oil has been used as a flavoring, perfumery, anti-
microbial,  anti-oxidant agents with other therapeutical applications.  
Eucalyptus Biological Activities   
E. globulus is characterized by biological activities of potential medicinal value which make it 
of great interest (Qabaha et al., 2016). Previous studies showed that E. globulus has been used 
for the treatment of various diseases such as fungal infection, diabetes, influenza, and pulmonary 
tuberculosis. Crude extract of the fruits of E. globulus has shown antioxidant and anti-bacterial 
activity (Makhlouf et al., 2013). Another study shows that the extract of E. globulus leaves 
reduced lipogenesis, inflammatory cytokine expression, and OS, as it inhibited NASH induced 
by fructose ingestion in rats (Takahashi et al., 2015). Furthermore, aqueous extract and the 
essential oil have a good anti-bacterial and antioxidant activity due to polyphenols and flavonoid 










Algal and Terrestrial species 
Collection 
Cystoseira compressa:  The brown seaweed C. compressa freshly collected from “Tyre Coast-
South Lebanon” in the period of April-June 2018; were washed and cleaned with water, dried at 
room temperature, and grinded for further extraction.  
Ferula hermonis: Roots of F. hermonis were harvested from “Mountains of Bekaa”, Lebanon, 
in August 2017. The roots were washed and cleaned with water, then dried at room temperature 
and grinded for further extraction. 
Eucalyptus globulus: purified FUC was provided by Professor Hussein Kanaan as it was 
extracted in 2017 at Laboratory of Chemical Synthesis and extraction of Polysaccharides from 
seaweed, Faculty of Pharmacy, Lebanese University.  
CYS, FER and EUC correspond to FUC purified from C. compressa, F. hermonis and E. 
globulus, respectively.   
 
 Extraction and Purification of Fucoidan  
Water‐soluble polysaccharides were obtained as previously described using slightly modified 
methods (Imbs et al., 2009; Ermakova et al., 2013) . Briefly, 100 g of  C. compressa and F. 
hermonis roots were extracted twice with 250 mL absolute ethanol for 3 h at 40 °C to remove 
low‐molecular‐weight compounds such as pigments, phenols, and proteins. The dried residues 
were extracted twice with aqueous hydrochloric acid (HCl) solution (pH = 2) at 60 °C for 3 h, 
then centrifuged at 1600× g for 20 min to obtain supernatant, containing the FLM complex 
(Fucoidan, Laminarin, Mannuronan). The supernatant was neutralized with 3% NaHCO3, 
evaporated in a Rotavac Vario Power Unit (Heidolph Instruments, Schwabach, Germany) to a 
final volume of 200 mL, which proceeded to 24 h dialysis (Spectra/Por Dialysis Tubing, MWCO 
12000‐14000) and subsequent lyophilization to obtain FLM powder. Fucoidan purification was 
obtained by adding 50 mL of aqueous HCl solution (pH = 2), followed by centrifugation at 
1600× g for 20 min. The pellet was discarded whereas supernatant was lyophilized to obtain dry 














A. Sulfate and Protein Content: Sulfate and protein content were determined by the 
turbidimetric assay described by Jackson and McCandless (1978). Reagents needed for 
these spectrophotometrical analysis are: 8% of trichloroacetic acid, and 0.01% agarose 
with or without Barium chloride for sulfate and protein content, respectively.  FUC 
samples (CYS, FER, AND EUC) were incubated with TCA and the corresponding 
agarose for 40 minutes at room temperature RT, then turbidity was measured at 500 nm.                              
Potassium Sulfate (K2SO4) and bovine serum albumin (BSA) were used as sulfate and 
protein standards, respectively.  
 
B. Sugar Content:  Sugar content was quantified using the phenol-sulfuric acid method 
developed by Dubois et al. (1956). 2 ml of the three purified FUC were incubated with 
0.5 ml of phenol (3%) and 5 ml of H2SO4 for 15 minutes at RT followed by absorbance 





recording at 520 nm. Fucose, glucose, galactose and mannose were used as sugar 





Functional Groups and Chemical Structure  
A. Fourier Transform Infrared spectroscopy (FTIR): The FTIR spectra of CYS, FER 
and EUC were recorded on a Perkin-Elmer FTIR spectrometer Spectrum Two UAT. 
Data were collected in the range of 4000-400 cm-1.  
 
B. Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectroscopy: Proton and carbon positions in CYS, FER and EUC were determined by 
analyzing NMR spectra using a Bruker Ascend 500 AVANCE III HD spectrometer. The 
water-soluble polysaccharide was dissolved in 99% deuterium oxide (D2O), and the 
spectra were recorded at room temperature (1H NMR: frequency 500 MHz, acquisition 
































Extraction Yield and Chemical Composition 
The yield of the FUC extraction from C. compressa and F. hermonis roots were 3.6% and 3.07%, 
respectively. Both greater than that from E. globulus, which was 2.1% according to a previous 
study (Haddad et al., 2017). The chemical composition of purified FUCs is shown in Table 2  
CYS,FER, and EUC contained significant amounts of fucose and sulfate groups, but also 
glucose, galactose, mannose, and a small amount of proteins were detected. 
 
Table 2:  Chemical composition (%) of fucoidan extracted from C. compressa, F. hermonis, 
and E. globulus Data are presented as mean ± SD of 3 experiments. 
In (%) Sulfate    Fucose                    Glucose    Galactose  Mannose  Proteins   
CYS 1.26 ± 6.1   22.3 ± 2.7 21.1± 5.3 1.99± 3.1  0.98±2.9 0.42 ± 6.3 
FER 1.8 ± 1.52   31.5 ± 6.1 29.3 ± 6.32 2.6 ± 5.82 1.2 ± 4.95 0.46 ± 7.6 




STRUCTURAL FEATURES  
FTIR spectroscopic analysis:  
➢ C. compressa 
The FT-IR spectrum of CYS  (Figure 7A) showed a wide band at 3415.31 cm-1 corresponding to 
O-H stretching vibrations. Two weak signals at wavelengths 2927.41 and 2049.96 cm-1 are  
assigned to C-H stretching of the pyranose ring and of the methyl group of fucose (Saboural et 
al., 2014).Furthermore, the small peak at 1726.94 cm-1 is due to the C=O bond of carboxylate 
group (Liang et al., 2019).  The band at 1619.91 cm-1 contributes to asymmetric vibrations of 
carboxylate anions O-C-O of uronic acid, glucoronate units (Huang et al., 2017). The band at 
1079.94 is assigned to the sulfate ester group (Haddad et al., 2017).  The band at 842.74 cm-1 
corresponds to sulfate peak (Patankar et al., 1993). Moreover, the band at 618.074 cm-1 are 









➢ F. hermonis 
As shown in Figure 7B, the FTIR spectrum of FER showed a wide band centered at 3301.02 cm-
1, which was assigned to hydrogen bonded O-H stretching vibration. The weak signal at 2926.7 
cm-1 indicated the presence of C-H (Sabourin et al., 2014). The band at 1595.49 cm-1  indicated 
the absorbance of uronic acid carbonyl group C=O, while that at 1410.07 cm-1 was assigned to 
carboxylate group vibrations (C–O). The weak band at 1273.21 cm-1 indicated the presence of 
S=O stretching vibration of the sulfate group, and that at 1028.88 cm-1 was due to a sulfate 
ester group (Myoung et al., 2011). Additional band at 530.98 cm-1 indicated the presence of 
C-O-S sulfate residues (Somasundaram et al., 2016).    
 
         
   
Figure 7: FTIR spectrum of fucoidan isolated from F. hermonis (A) and C. compressa (B).  









Nuclear Magnetic Resonance analysis:  
➢ C. compressa 
As shown in figure 8A 1H NMR analysis of CYS indicate the presence of a chemical shift 
between 0.61 and 1.15 ppm that corresponds to three hydrogen groups of a methyl group which 
is a main characterization of L-fucopyranose backbone. Another signal spread from 3.5 to 3.8 
ppm are related to five ring protons  indicating the presence of different fucose sulfate group 
types (Alwarsamy et al., 2016)  
 
        
Figure 8A: 1H NMR of fucoidan purified from C. compressa.  
 
➢ F. hermonis:  
The Proton (1H) NMR analysis of FER is shown in Figure 8B. The 1H NMR spectrum contained 
chemical shifts ranging from 5.0 to 5.7 ppm that are consistent with the presence of protons 
(H1α) of α‐linked‐l‐fucose and β‐linked sugars (H1β). Chemical shifts indicated between 0.75 
and 1.81 ppm corresponded to the methyl group which is a main characterization of L‐
fucopyranose (L‐FucP). The spectrum contained resonance characteristics of FUC with signals 
from ring protons (H‐2 to H‐5) at 3.46–4.20 ppm that support the presence of different types of 
fucosal sulfate groups with changes in glycosidic linkage positions and monosaccharide patterns 
(Alwarsamy et al., 2016) (Ajisaka et al., 2015). Furthermore, 1H signals due to linear 
unsubstituted L‐fucose resonated at 5.07 to 5.22 ppm and the signals at 5.38–5.39 ppm could be 








The 13C NMR spectrum of FER reported in Figure 8B showed major signals of sulfated L‐fucan 
between 92.2 and 103.7 ppm (C1) and at 16.6 ppm (C6). The signals obtained in the region 60.2 
and 82.0 ppm corresponded to pyranoid ring carbons (C2‐C5) (Alwarsamy et al., 2016) (Haddad 
et al., 2017). In the 13C NMR spectrum of FER there are at least seven separate anomeric carbon 
signals. The C6 signal of presumably glucose is visible at 62.4 ppm.  
 
    
     










   
Previously, several studies demonstrated that fucoidan polysaccharide possesses a wide 
spectrum of biological activities such as antitumor, antioxidant, anticoagulant, antithrombotic, 
immune-regulatory, anti-viral, anti-inflammatory and anti-steatotic; thus FUC can be considered 
a suitable candidate for several therapeutic and pharmaceutical applications (Wang et al., 2019 
(Yokota et al., 2016). Brown algae are considered the main source of FUC (Kylin H. et al., 
1913). Recently FUC has been isolated and characterized from the leaves of E. globulus, a 
terrestrial tree known to be used as a medicinal plant. 
This inspired us to extract fucoidan from the brown algae Cystoseira compressa collected from 
the Lebanese coast, as well as from the terrestrial plant Ferula hermonis for the first time.  
Our results indicated that the extraction yield of FUC from C. compressa (3.6%) was greater 
than that from F. hermonis which was 3.07% (El Rashed et al., 2021); while about the same 
yield obtained for FUC purified from E. globulus according to a previous study (Zein et al., 
2018). Moreover, FUC yield from C. compressa was close to that obtained from the same species 
extracted in previous studies, where it was 5.2% (Hentati et al., 2018). The difference in FUC 
content varies between species and even in the same species it depends on the source of algae as 
well as the environmental changes.  
Chemical composition analysis of CYS, FER and EUC extracts revealed the presence of 
sulfates, fucose, and glucose groups in high percentages, while smaller quantities of other 
monosaccharides and proteins were detected. EUC has shown to contain a higher amount of all 
components abovementioned as compared to FER and CYS. Thus, chemical composition as well 
as extraction yield can be affected by several factors including species difference, seasonal 
variations, environmental changes, and extraction methods. (Zhao et al., 2018). 
 
The chemical structure of FUC extracted from C. compressa and F. hermonis investigated by 
FTIR and NMR confirmed the presence of functional groups that characterize fucoidans such as 
fucopyranosyl units and sulfate groups.  
With the exception of peaks detected at 2049.96 cm-1, 1619.91 cm-1 and 618.074 cm-1, the FT-
IR spectra of fucoidan purified from C. compressa showed similarities in their infrared 
absorption properties compared to that isolated from E. globulus as previously studied (Zein et 
al., 2018). Few differences are obtained also when comparing CYS and FER FTIR, where CYS 
show an additional peak at 618.074 cm-1 corresponding to C-C-H stretching vibrations while 
FER spectra indicated the presence of sulfate group at 1273.21 cm-1. Moreover, IR spectra 
indicated a difference in sulfate substitutions in which CYS spectrum indicates the presence of 
absorption at 842.72 cm-1 corresponding to the sulfate groups at the axial C-4 position while 
sulfate substitution of EUC were located in the equatorial C-2 and/or C-3 positions (Patankar et 





factors that can lead to chemical composition variation which in turn affect the bioactivity of the 






In this study, we were able to purify fucoidan from the brown algae C. compressa collected from 
Lebanese cost, as well as from the terrestrial plant F. hermonis for the first time. The chemical 
features and functional groups of purified fucoidan were investigated by studying the spectra of 
FUC by Fourier Transform Infrared and nuclear magnetic resonance. Furthermore, the chemical 
composition of CYS, FER, and EUC was demonstrated by several assays that investigate fucose, 
sugar, sulfate, and protein content. Different yields, functional groups, and chemical 
compositions were obtained for the three vegetal species with different environments.  
We confirmed that FUC structure is determined by the vegetal species and environmental 
factors, which encourages us to check if this will lead to the difference in biological activities 
associated with this water-soluble polysaccharide.  
 
In the next study, the antioxidant activity of FUC will be investigated by several 


















CHAPTER II: ANTIOXIDANT ACTIVITY OF 
FUCOIDAN EXTRACTED FROM C. compressa,  
F. hermonis, and E. globulus.   
 
 
                                                                         
                                                                                              
                                                                         
                                                                         
                                                                     
 
Define the problem:                                                                   
• Oxidative stress is a common state among 
several  
disease, especially metabolic diseases (MS).  
• Search for new natural antioxidant compounds.  
 
Chapter Research Question:  
• Does FUC purified from three different 
species have antioxidant activities.  









Oxidative stress (OS) is a common cause of most of the non-communicable diseases of the 
modern age and is caused by reactive oxygen species generated by  biological systems through 
metabolism and environmental. Endogenously biological systems have their own natural 
defense antioxidant mechanisms, yet they cannot prevent the entire oxidative damage leading to 
the use of synthetic drugs that have several side effects. Therefore, there is an increase in the  
search for biologically active natural compounds that can repair OS by delaying or preventing 
the negative effect caused by free radicals. Fucoidan, the water-soluble polysaccharide is 
characterized by one of the main biological potentialities of phytochemicals, which is 
antioxidant activity. Antioxidant potentials for fucoidan purified from the three different species 
were investigated by several assays; DPPH assay, ABTS assay and FRAP assay. Furthermore, 
FUC protective role from oxidative damage to erythrocyte was assessed by anti-hemolysis assay.  
Our results indicated that CYS, FER, and EUC exhibit good antioxidant potentials, with EUC 
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“Oxidative stress is an imbalance between oxidants and antioxidants in favor of the 
oxidants , leading to a disruption of redox signaling and molecular damage” 
 
Oxidants: Definition and Sources 
Cancers, strokes, arthritis, aging, autoimmune disorders, diabetes, cardiovascular, 
neurodegenerative diseases, and liver diseases seem as different from one another as any 
diseases could be, which makes it hard to imagine them sharing a single feature. However, there 
is an integration of OS almost in all areas of human pathology. Oxidants collectively describes 
both free radical and other non-radical reactive derivatives.  
 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are highly unstable 
molecules derived from oxygen and nitrogen molecules that are divided into free radicals and 
non-radical molecules.  
➢ Free radicals are atoms, molecules or ions that are unstable and highly reactive with other 
molecules due to their unpaired electrons. These free radicals include hydroxyl (OH•), 
superoxide (O2•–), nitric oxide (NO•), nitrogen dioxide (NO2•); as molecular oxygen 
being the main source of radicals in biological systems.  
 
➢ Other molecules such as hydrogen peroxide (H2O2) and peroxynitrite are non-radical 
ROS but can give rise to free radicals upon further metabolisms in biological systems.  
 
 
Reactive species (RS) are products of normal cellular metabolism with an important role in 
signaling pathways. Inside the cell, RS are produced as a result of extracellular or intracellular 
stimuli. Extracellular stimuli on plasma membrane receptors generate RS through tumor necrosis 
factor- (TNF-) α, hormones (insulin), and growth factors (platelet-derived growth factor (PDGF) 
and epithelial growth factor (EGF)).  While intracellular stimuli generate (RS) by activating 
several are induced by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, 






Moreover, the exogenous source of oxidants results from the air and aqueous pollution, cigarette 
smoke, alcohol, heavy or transition metals (Hg, As), industrial solvents, cooking (smoked meat, 
used oil, fat), and radiation. After penetration into the body by different routes, these exogenous 
compounds are decomposed or metabolized into free radicals (Betteridge et al., 2000).  
 
 
Oxidants: Biological Effects 
Free radicals are initially produced by the body, but what makes such species play a dual role as 
both toxic and beneficial compounds is their level in the body. At low or moderate levels, ROS 
and RNS are safe for normal biological functions of mitochondria, cell, and tissues; in which 
they are implicated in vital roles of cell proliferation, differentiation, migration, and immune 
response. For example, phagocytes (neutrophils, macrophages, monocytes) release free radicals 
to destroy invading pathogenic microbes. Another example is the free radical nitric oxide (NO) 
which plays a role as an intercellular messenger for modulating blood flow, thrombosis, neural 
activity, and for killing intracellular pathogens and tumors (Zorov et al., 2014). 
On the other side, excessive amounts of ROS can lead to deleterious effects when interacting 
with other molecules such as lipids, proteins, and DNA causing cell damage and DNA lesions.  
 
As abovementioned, several organelles contribute to OS in specific ways that will be explained 
below.  
 
Mitochondrial ROS Production  
Within most mammalian cells, mitochondria are an important source for ROS production in 
which ROS contribute to mitochondrial damage and dysfunction in a range of pathologies. The 
first evidence on mitochondrial ROS (mtROS) production was recorded in 1961 by Jensen et al 
who observed that a small portion of oxygen consumed by the mitochondrial respiratory chain 
was converted to H2O2. Then, the mtROS research era was initiated in 1970’s and since that time 
“artificial” systems such as isolated mitochondria, inside-out submitochondrial particles, 
reconstituted respiratory complexes, and pure enzymes have been used to study physiological 
processes.  mtROS generation takes place at electron transport chain (ETC) located on the inner 
mitochondrial membrane where normally ATP is produced through cellular oxidative 
phosphorylation (detailed in chapter III). However, this process is not perfect in some cases 
where electrons leakage leads to a partial reduction of oxygen to form superoxide (O2
-). 
Furthermore, O2
- undergoes dismutation into H2O2 by superoxide dismutase enzyme; notice that 
there are two forms of SOD (SOD1 in mitochondrial intermembrane space and SOD2 in the 






At the mitochondrial level, ROS can damage proteins, membranes, and lipids leading to 
defective protein synthesis and thus impairing the mitochondrial ability to allow a wide range of 
metabolic reactions such as Krebs cycle, fatty acid oxidation, amino acid metabolism, and the 
urea cycle. Moreover, OS activates apoptotic machinery by increasing the capacity of 
mitochondria to release intermembrane space proteins such as cytochrome c (cyt c) to the cytosol 
by mitochondrial outer membrane permeabilization (MOMP) (Murphy et al., 2009).  
 
 
Peroxisomal ROS Production 
As mitochondria is the major source for ROS generation, peroxisomes are considered as central 
organelles within ROS generation and scavenging. Peroxisomes are involved in fatty acid α-
oxidation, β-oxidation of very long chain fatty acids, catabolism of purines, and biosynthesis of 
glycerol-lipids and bile acids. They are rich in O2 consuming oxidases , acyl-CoA oxidase, 
xanthine oxidase, D-amino acid oxidase, and nitric oxide synthase which result in the production 
of H2O2, O2
-  and nitric oxide ˙NO as byproducts. (Bonekamp et al., 2009).   
 
Endoplasmic Reticulum and ROS Production 
Endoplasmic reticulum (ER) organelle is responsible for protein synthesis, folding, maturation, 
and assembly. Under several conditions unfolded or misfolded proteins are accumulated within 
ER lumen leading to ER stress which in turn induces ROS production and depletes reduced 
















On the other side the body overcomes the oxidative stress; either by endogenous antioxidants 
produced by the body or by exogenous antioxidants supplied through food, they exert their effect 
by different mechanisms: suppress radical formation; act as scavengers and acting as their 
substrate (Huang et al., 2005).    
The major endogenous antioxidants are superoxide dismutase (SOD), catalase, glutathione 
peroxidase and glutathione reductase. In addition to exogenous antioxidants provided by diet 
and medicinal plants. Normally, prooxidant are in balance with antioxidant mechanisms, while 
in case of OS an imbalance occurs in favor to oxidants.  
 
Supplementary Box 3: Antioxidant Enzymes  
Superoxide Dismutase: It is an antioxidant defense enzyme that catalyzes the 
dismutation of  O2
-  into O2 and H2O2.  
Catalase:  This common antioxidant enzyme catalyzes the decomposition of H2O2 into 
H2O and O2.  
Glutathione peroxidase: It is an enzyme with peroxidase activity whose main function 
is to prevent oxidative damage. It catalyzes the reduction of hydrogen peroxide to water 
and oxygen as well as catalyzing the reduction of peroxides radicals to alcohols and 
oxygen.  
Glutathione reductase: This enzyme catalyzes the reduction of glutathione disulfide to 
the reduced form glutathione.  
 
Antioxidant Activities of Natural Compounds  
Since the beginning of this century, the use of synthetic antioxidants that are inspired by natural 
scaffolds including vitamins C and E, and phenolic compounds have been increased. Used 
synthetic compounds are reported to be safe have been used in food products;  although some 
studies indicate otherwise, such as the examples of butylated hydroxytoluene and butylated 
hydroxyanisole, which are the most widely used chemical antioxidants. However, several 
restrictions have limited the use of these synthetic compounds because of their long-term effects, 
and the focus of consumers on the reduction of synthetic additives or their replacement by natural 
products. Thus, studies have been directed to investigate the potential of natural products to 
serve as antioxidants for protection against free radicals. A simple search for antioxidant 
activities of natural compounds results in 43,800,000 articles.  Such natural bioactive 






Mechanisms of Action of Antioxidants  
Plant extracts or their purified compounds show significant antioxidant activities. They act by 
several mechanisms listed below, all aimed to reduce OS by directly reacting with the reactive 
radicals and destroy them or producing new free radicals which are less active and less dangerous 
than those radicals they have neutralized. Moreover, such compounds can help to protect cellular 
damages from OS by inhibiting the activities or expressions of free radical generating enzymes 
such as NADPH oxidase and xanthine oxidase (XO) or inducing the expression and  activity of 
antioxidant enzymes such as SOD, catalase, and glutathione peroxidase (Lü et al., 2010).  
➢ Scavenging radicals, superoxide, and other ROS. 
➢ Metal ion ((Fe2+, Fe3+, Cu2+ and Cu+) chelating.  
➢ Inhibition of free radical generating enzymes. 
➢ Activating intracellular antioxidant enzymes. 
➢ DNA protection from damage. 





METHODS for ANTIOXIDANT ACTIVITY QUANTIFICATION  
 
Due to the contribution of OS in several pathologies and antioxidants significant role in 
scavenging ROS, several methods have been used to determine the antioxidant activity of 
phytochemicals. Based on the mechanism of action, and from a chemical point of view available 
methods for antioxidant capacity quantification are divided into three groups. 
A. Electron-Transfer-Based Assays: antioxidants transfer an electron to reduce 
metal ions, carbonyls, and radicals.  
Examples: DPPH free radical scavenging assay, Ferric reducing antioxidant power 
(FRAP), and Trolox equivalent antioxidant capacity (TEAC) assay. 
 
B. Hydrogen-Atom Transfer Reactions: This type of assays depends on 
antioxidant’s ability to “quench/intercept” free radicals by detaching a hydrogen 
atom.  
Examples: Total radical trapping antioxidant parameter (TRAP), and Oxygen 






We will explain in a detailed way the principle and advantages of the three assays “DPPH, 
FRAP, AND TEAC”  
 
DPPH ASSAY: DPPH (1,1-diphenyl-2-picrylhydrazyl) is a stable radical with a deep violet 
color that turns yellow when scavenged by a reducing agent (antioxidant), and this is monitored 
quantitively by spectrophotometrical reading of the absorbance decrease at 515 nm.  
 
FRAP ASSAY: is a colorimetric redox-linked assay that measures the ferric reducing activity 
of the sample at low pH conditions, based on ferric tripyridyltriazine complex (Fe3+-TPTZ) 
reduction to a ferrous (Fe2+-TPTZ) form by antioxidants present in tested material. Results are 
quantified as an increase in absorbance at 593 nm is proportional to the total Fe3+ reducing power 
of the tested sample which is quantitated at an absorption maximum of 593 nm.  
 
ABTS ASSAY: this assay depends on ABTS•+ free radical which are generated when ABTS 
substrate is oxidized with potassium persulfate. ABTS•+ has a blue/green color, and decolorized 
when reduced in the presence of reducing agent. It is a spectrophotometrical method where 
ABTS•+ maximum absorption spectrum is monitored at 734 nm and called TEAC because he 
antioxidant capacity of the sample is measured in comparison to Trolox as a standard  (Shalaby 
et al., 2013) (Ivanova et al., 2020) (Liang et al., 2014).  
 
 
Table 3: Advantages and disadvantages of antioxidant quantification methods .  
Methods Advantages Disadvantages 
DPPH Easy, rapid, inexpensive, 
effective and the most widely 
used assay for plant screening.  
Not an exact model of radical reactions in 
biological systems since DPPH is a long-lived 
radical that does not resemble the highly 
ROS 
FRAP Simple, highly reproducible, 
and inexpensive assay 
The required low pH, acidic conditions is 
considered a strong deviation from body 
physiological conditions.  
ABTS Rapid, flexible to a wide pH 
range, and soluble in both 
aqueous and organic solvent 
which means that this assay is 
applicable to hydrophilic or 
lipophilic compounds. 
ABTS reagent is quite expensive. 
More accuracy is required for  an oxidizing 
agent used to generate ABTS•+; time and 
storage conditions of the solution; and 









The aim of this study was to investigate and compare the antioxidant capacity of FUCs purified 
from C. compressa, F. hermonis, and E. globulus by different assays.  
 
Furthermore, we aimed to test the protective effects of CYS, FER, and EUC on erythrocytes 

















RADICAL SCAVENGING ACTIVITY 
 
DPPH (2, 2-diphenyl-1-picrylhydrazyl radical) assay  
The capacity of FUC to scavenge the free-radical 2, 2-diphenyl-1-picrylhydrazyl (DPPH) was 
determined basically according to the method described by Haddad et al (2017). One mL 
aliquots of FUC purified from the three species, at different concentrations (50-500 μg/mL for 
CYS and FER; 2.5-500 μg/mL for EUC) were prepared and mixed with 1 mL of DPPH solution 
(0.05 g/L in methanol). After a 30 min incubation in darkness, the DPPH radical reduction was 
evaluated by reading the absorbance at 517 nm using a Gene Quant 1300 UV-VIS 
spectrophotometer. 
 Ascorbic acid was used as the reference standard. The results were calculated as follows: DPPH 
scavenging activity (%) = [(Absorbance of control – Absorbance of sample)/ (Absorbance of 
control)] X 100. The IC50 value, defined as the concentration of CYS,FER, AND EUC required 





The ABTS assay was performed following the procedure described previously (Benelli et al. 
2018), applied to a 96-well microplate. The ABTS·+ stock solution was prepared according to 
Miller and Rice-Evans (1997) to obtain a final solution with absorbance about 1 at 734 nm. FUC 
extracts at different concentrations (31.25-2000 μg/mL for CYS; 6.25-400 μg/mL for FER; 
3.125-200 μg/mL for EUC)  were incubated with ABTS·+ for 10 minutes then results were read 
at 734 nm using a microplate reader (FLUOstar Optima, BMG Lab-tech microplate reader).  
Trolox was used as a reference and results were expressed as µmol Trolox Equivalents (TE)/g 
of extract (µmol TE/g). The IC50 value, defined as the concentration of CYS, FER, and EUC 
required to cause a 50% reduction in the assay was expressed in μg/mL and estimated by a 









FRAP assay   
FRAP assay was performed as previously reported (Benelli et al., 2018) by using a 96-well 
microplate to monitor the reduction of Fe3+ tripyridyl triazine (TPTZ) to blue-colored Fe2+-
TPTZ. Fresh working solution was prepared by mixing 10 volumes of acetate buffer (300 mM, 
pH 3.6), 1 volume of TPTZ (10 mM in 40 mM HCl), and 1 volume of FeCl3.6 H2O (20 mM). 
Different concentrations of FUC (31.25-2000 μg/mL for CYS; 6.25-400 μg/mL for FER; 3.125-
200 μg/mL for EUC) were incubated with FRAP solution for 10 minutes and the absorbance of 
Fe2+-TPTZ was read at 593 nm with Trolox as standard as described above for ABTS. 
 
Anti-hemolytic activity  
Human blood was obtained from healthy volunteers in the medical laboratory of Public Health 
Faculty- Lebanese University, washed three times in 9 volumes of Phosphate Buffered Saline 
(PBS) and centrifuged for 10 min (2500 rpm; 4 °C). Cell pellet was diluted 1:20 (v/v) in sterile 
PBS to form Red Blood Cell (RBC) suspension in which (1 mL) was mixed with purified CYS, 
FER, or EUC at 50 μg/mL. After 5 min, 30 µl of 30 % (w/w) H2O2 solution were added, 
incubated at 37°C for 1.5 h and then centrifuged for 10 min (2500 rpm; 4 °C). Results were 
recorded by reading the absorbance of the supernatant at 540 nm (James et al., 2014). Data were 





















DPPH assay results for the three FUC extracts indicated that radical scavenging activity 
increases as FUC concentration increase. As shown in figure 9, CYS and FER have 
approximately the same pattern of increase and same FUC concentration in which IC 50 was 
152.62 µg/ml and 157.59 µg/ml, approximately. However, DPPH assay for FUC purified from 
E. globulus required to start with a lower EUC concentration due to its high antioxidant activity, 
where IC 50 obtained was 4.466 µg/ml.  
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Figure 9: DPPH radical scavenging activity of CYS, FER, and EUC as function of increased  FUC 
concentration in µg/ml.  
ABTS and FRAP:  
As shown in Table 4, FUC extracted from C. compressa, F. hermonis, and E. globulus showed 
high scavenging capacity when measured with both assays. For ABTS assay, the high TEAC 
obtained for FER and EUC, and the small IC50 suggested that FER and EUC are more active 
than CYS. IC50 of EUC and FER were higher than that of Trolox only by 3 and 10 times, 
respectively.  
Same results obtained with FRAP, as TEAC values reflected the significant antioxidant activity 
of FUC.  
 
Table 4:  Antioxidant activities of CYS, FER and EUC measured by ABTS and FRAP assays. 







CYS 38.99 ± (3.7) 478.6 ± (39.24)                    77.18 ± (9.1) 
FER 
410.0 ± (14.0) 
 
44.26  (2.35) 
 
81.30  (7.2) 
EUC 1444.05 ± (11.5) 
 
12.92 ± (0.81) 
 
638.87 ± (17) 
Trolox  4.53  (1.53)  
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Preliminary experiments in our study indicated that none of CYS, FER, or  EUC show any 
hemolytic ability (data not shown). Then, anti-hemolysis activity of FUC at a concentration 50 
µg/ml was tested in the presence of H2O2. Our results in Figure 10 show that CYS, FER, and 
EUC decrease the hemolytic percentage with respect to H2O2 treatment by 15.5%, 20.9% and 
28%, respectively. This decrease was significant only for FER (p ≤ 0.05) and EUC (p ≤ 0.01). 
 
     
Figure 10: Anti-hemolytic activity of CYS, FER and EUC at a concentration 50 µg/ml. Data are 
expressed as percentage of hemolysis. Values are mean ± S.D. from three independent 




DPPH, ABTS and FRAP assays were used as easy, rapid, and sensitive methods to determine 
the scavenging capacity of FUC against different radicals. In the three tested assays, EUC 
showed to be the most potent antioxidant purified fucoidan, followed by FER, and then CYS. 
The difference in antioxidant activity could be attributed to different mechanisms, such as 
complex with transition metal ion catalysts, break of chain initiation, radical scavenging 
prevention and increase of reductive capacity. All these properties have been described for other 
water-soluble polysaccharides and fucoidan fractions previously characterized from different 
sources (Zou et al., 2008; Laeliocattleya R.A. et al. 2020, Aji-saka K., et al. 2016, Wang Y. et 
al. 2019, Haddad et al., 2017). Previous studies indicated that FUC purified from C. compressa 
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gastric mucosal damage (Hentati et al., 2018). Crude extract of the fruits of E. globulus have 
shown antioxidant and anti-bacterial activity (Makhlouf et al., 2013). Furthermore, 
sesquiterpene ferutinin, the main bioactive compound purified from Ferula genus is 
characterized by several biological activities, most importantly antioxidant effects (Macrì et al., 
2020). In addition to other studies that demonstrated the antioxidant activity of F. hermonis 
extract.   
 
The most plentiful cells in the human body are found to be the erythrocytes, which own copious 
biological and morphological characteristics, hence they have been widely exploited in drug 
transport. OS to erythrocytes can lead to their hemolysis. Our results indicated that FUC purified 






Being OS a common cause of most of the non‐communicable diseases of  the modern age, the 
antioxidant activity is perhaps one of the main biological potentialities of phytochemicals in 
general and particularly of FUC. In this study three different methods were used to characterize 
FUC antioxidant capacity, results showed that CYS, FER, and EUC  exhibited a good 
scavenging activity against DPPH and ABTS radicals, as well as a ferric reducing power with 
that purified from E. globulus being the most potent polysaccharide. Moreover, the radical 
scavenging capacity of FUC was tested in a cellular model; erythrocytes, where protective and 
preventing the antioxidant ability of the polysaccharide decreased hemolysis percentage when 
incubated with H2O2.  
 
 
These promising results encourage us more to continue studying the biological activities of 
FUC using two in vitro cellular models. In the next chapter will show the hepatoprotective 













Chapter III: Anti-Steatotic and Antioxidant Activities 
comparison of marine derived Fucoidan (C. 
compressa) and terrestrial fucoidans (F. hermonis, 
and E. globulus ) 
 
                                                         
 
                                                                                                    
  
 
                                
                                                                                       
 
Define the problem: 
Nonalcoholic fatty liver disease is a 
metabolic manifestation of liver disease.  
Its prevalence in increasing to reach 25% 
of general population. Several risks are 
associated with its pathogenesis.  
Drugs used to treat NAFLD are still 
limited due to their side effects 
 
Research questions: 
FUC as a bioactive compound to 
treat NAFLD: 
➢ Does FUC have any lipid lowering 
effects? 
➢ Does FUC decreased ROS 
production in NAFLD models? 









Nonalcoholic fatty liver disease is a metabolic disorder characterized by lipid overloading in 
hepatocytes that can progress to more severe pathologies such as nonalcoholic steatohepatitis 
(NASH), fibrosis, cirrhosis, and eventually hepatocellular carcinoma. Such pathogenesis and 
worsening are complex and sustained by the synergetic action of a variety of nutritional, 
environmental, metabolic, and hormonal factors.  NAFLD pharmacological treatment is still 
limited by unwanted side effects, whereas the use of food components with therapeutic potential 
is advisable. The culinary use of marine algae is traditional for some populations and reviving 
worldwide, with promising health outcomes due to the large number of bioactive compounds 
found in seaweeds. In vitro and in vivo studies demonstrate that fucoidan;  a brown-algal derived 
polysaccharide exert beneficial actions on satiety feeling, caloric intake, fat absorption, and 
modulation of the gut microbiota, which could account for indirect effects on energy and lipid 
homeostasis, thus diminishing the fat overload in the liver. In this study, we aimed to investigate 
the anti-steatotic and antioxidant effects of CYS, FER, and EUC using in vitro cellular models 
of NAFLD and endothelial damage (rat hepatoma FaO cells and human endothelial HECV cell 
lines). Results showed that FUC purified from the brown algae and two terrestrial plants exert 
both antioxidant and anti-steatotic effects as they reduced the ROS production and triglyceride 
content and regulate the expression of genes implicated in lipid metabolism by inhibiting the 
expression of lipogenic genes. Fucoidan purified from E. globulus was the most effective extract 
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The liver is the heaviest internal organ and the largest gland in the body, being around 2-3% of 
body weight. It is located in the right upper quadrant of the abdominal cavity, beneath the right 
hemi-diaphragm, to the right of the stomach, protected by the rib cage and overlying gall bladder. 
It’s close location to the spleen, pancreas, stomach, and intestine is appropriate for its importance 
as the body’s chemical “factory”. This factory is responsible for hundreds of separate functions, 
either in an exocrine or endocrine manner, such as bile production, protein and metabolite 
synthesis, metabolic reactions, hormone catabolism, drug detoxification, and many other 
important functions.  
 
 Liver structure 
 The liver is a reddish-brown organ, mainly divided into two lobes when viewed from above 
(right and left) or divided into 4 unequal lobes  when viewed from below. The lobules are held 
together by a fine connective tissue known as Glisson’s capsule. Furthermore, left and right lobes 
are divided by a thin fold of peritoneum called a falciform ligament. As mentioned above, the 
liver relates to the diaphragm by a triangular zone known as the bare area. Apart from this bare 
area, all the liver is covered by a thin, double layered mesothelial membrane derived also from 
the peritoneum to reduce friction with other organs.  
       








The liver parenchyma is divided into polygonal basic units known as lobules, formed by 
numerous laminae of hepatocytes along with sinusoids, and a triad composed of the hepatic 
portal vein, hepatic artery, and bile duct. The hepatic artery and hepatic portal vein branches 
pass from the periphery toward the central lobule, forming sinusoids with thin pores called 
fenestrae. The center of the lobule is occupied by the central vein.  
The hepatic sinusoids are thin-walled, broad-lumen blood capillaries characterized by the 
presence of pores and fenestrated endothelial cells. Between the endothelial cells of the sinusoids 
and the hepatocytes there is a space with a reticular connective texture called the Disse space.  
On the sides of the Disse space there are two laminae: that of the endothelial cells and that of 
the basal area of the hepatocytes, that have microvilli to increase the exchange surface. Plasma 
can pass through the fenestrations of the endothelial cells and partially travels in the space of 
Disse (Trefts et al., 2017).  
BLOOD FLOW: Blood flow to the liver represents around 25% of total cardiac output and it 
reaches around 1500 ml/min. The hepatic artery, branching from the aorta, carries oxygenated 
blood, and provides around 25 % of liver blood input. However, the remaining 75 % is supplied 
by the hepatic portal vein, and it is rich in nutrients, hormones, and glucose.  
At the level of sinusoids, blood delivers O2, nutrients, sugar, and simple amino acids to 
hepatocytes. As the blood circulation is centripetal, there is a gradient of O2 supply to 
hepatocytes from the portal triad to the central vein, which makes the cells close to the portal 
space the most metabolically active.  
Concerning the hepatic output, after O2 and nutrient exchange at the  sinusoidal level, blood 
drains into the central vein of each lobule, that all together form the hepatic vein, which drains 
de-oxygenated blood into the inferior vena cava (Yamanaka et al., 1976). 
 
Supplementary Box 4: CELL TYPES OF THE LIVER  
The liver is made up of different cell types which can be divided into two main 
categories: parenchymal and non-parenchymal cells.  
➢ PARENCHYMAL CELLS Hepatocyte parenchymal cells make up about 60% of the 
liver cell population. They are highly specialized epithelial cells with the increased 
surface area for exchange with the vessels. The hepatocyte is one of the most 
metabolically active cells, very rich in organelles: smooth and rough ER, Golgi 
apparatus, lysosomes, peroxisomes, and most abundantly mitochondria.  
➢ NON-PARENCHYMAL CELLS The remaining 40% of liver cells are non-parenchymal 
cells, which include the fenestrated epithelial cells lining the sinusoids, and 





are considered tissue macrophages that perform a protective role against 
bacteria, viruses, and immune complexes) (Lau et al., 2003).   
 
 
                                                 LIVER FUNCTIONS 
The liver is an essential organ with many functions. These important functions include endocrine 
and exocrine regulation, bile production, hematopoietic, and detoxifying actions. Moreover, the 






                                                   
 
                                                          
 
 
               Figure 12: A diagram showing different liver functions.  
 
XENOBIOTIC DETOXIFICATION 
Xenobiotic is defined as any foreign substance, including natural and synthetic drugs, industrial 
chemicals, naturally occurring poison and environmental pollutants. They are almost 
hydrophobic, a characteristic that allows their absorption through the gastrointestinal tract, skin 
and lungs; once detected as a foreign substance, the body  metabolically transforms such 
substances to more hydrophilic ones, in order to be secreted in urine, plasma, bile, sweat, or 




























reduced to produce completely or partially inactive metabolites. Around 75% of all 
biotransformation reactions occurring with the aim of detoxification take place at the level of 




Glucose can be phosphorylated into glucose 6-phosphate, and isomerized into glucose 1-
phosphate  
Then, glucose 1-phosphate is catalyzed into Uridine 5’ diphosphate (UDP)-glucose by glucose 
1-phosphate uridyltransferase in the presence of Uridine-5'-triphosphate (UTP) and Mg2+. In the 
liver, UDP-glucose is involved in several metabolic pathways; UDP glucose is the glucose donor 
for glycogen synthesis by glycogen synthase enzyme, or it can be involved in UDP-
glucuronidation that converts some endogenous and exogenous compounds into more polar 
metabolites, thus facilitating their metabolism and secretion. Furthermore, UDP-glucose can be 
utilized in the synthesis of UDP-galactose from galactose 1-phosphate; then UDP-galactose can 
be implicated in lactose, glycoproteins, glycolipids, and glycosaminoglycan synthesis by 
transferring/donating a galactose unit.  
Around 50 % of ingested glucose is stored as glycogen showing the importance of this pathway 
that may lead to glucose metabolism disturbances in case of gene mutations or  enzymatic 
dysfunctions.   
 
BILE SYNTHESIS 
Bile is a yellow-green fluid synthesized by the liver, made of bile acids, bilirubin, phospholipids, 
cholesterol, xenobiotics, water, electrolytes, glutathione, IgA antibodies and other components. 
Cholesterol is a main component of the bile, as it is also a precursor for bile acids. The liver 
produces around 900 ml of bile per day, which in part are stored in the gall bladder, and the 
remaining are distributed along with the biliary system. Bile stored in the gall bladder is 
concentrated, and it is critical as an emulsifying agent in the digestion and absorption of fats and 
fat-soluble vitamins in the small intestine. Bile secretion is considered also as a pathway by 
which cholesterol, pigments produced from hemoglobin breakdown, and other waste products 
are eliminated from the body. Cholesterol, bilirubin, and phospholipids synthesis is explained in 















Supplementary Box 5:  Cholesterol Synthesis  
Cholesterol enters the smooth ER to undergo some hydroxylation reactions by 
cytochrome P450 (CYPs) enzymes, specifically CYP7E1 (7-α-hydroxylase) to give 
chenodeoxycholic acid or by CYP7E1 then CYP8B1 (12- α-hydroxylase) to give cholic 
acid. Both bile acids, also known as primary bile acids, can be either conjugated into 
more polar molecules or transported to biliary canaliculi by a bile salt export pump. In 
the intestine, they can be metabolized by bacterial enzymes producing the secondary bile 
acids deoxycholic acid and lithocholic acid through dihydroxylation reactions. Even if 
bile acids count for 70 % of bile components,  their excess  is hepatotoxic,  which can 
explain the negative feedback that chenodeoxycholic acid and cholic acid can exert on 
the rate limiting enzyme CYP7E1. 
 Regarding bilirubin, it is the breakdown product of hemoglobin, knowing that 
hemoglobin breakage ends in globin and heme group production. The latter is degraded 
into biliverdin and Fe2+. Biliverdin bounded to albumin protein is then transported to the 
biliary canaliculi as a component of the bile, but also it can pass to the intestinal tract, 
where it undergoes some metabolism by bacterial enzymes, resulting in two pigments, 
urobilin and stercobilin. Phospholipids are synthesized mainly from the fatty acids, and 
together with amino acids, water, electrolytes (sodium, chloride, and bicarbonate) and 




The liver is known to be a protein FACTORY, in which hepatocytes are responsible to 
synthesize most of the plasma proteins. Below are some examples of such proteins with their 
function (De Feo, 2002).  
  Table 5: The function of several proteins synthesized by the liver.  
Protein Function  
Albumin Counts for 60 % of plasma proteins, regulates osmotic blood 








 Factor XIII, XII, XI, X, IX, VII, V, II, and I also known as fibrin- 
stabilizing factor, Hageman factor, plasma thromboplastin 
antecedent, Stuart-Power factor,  Christmas factor, stabilizing 
factor, proaccelerin, prothrombin, and fibrinogen. Control bleeding 
and  their activation is vitamin K dependent.   
Anticoagulants • Plasmin: degrades many plasma proteins (factor V, VIII, 
platelet receptors), and mainly fibrin clot into fibrinogen.  
• Anti-thrombin: Deactivates factor II, IX, and X. 
Alpha and beta 
globulins 
Some globulins are made by the immune system, aid in the 
transport of lipid soluble substances like steroid hormones 
• Ceruloplasmin and transferrin for Cupper and Iron transport, 
respectively.  
• Haptoglobin which binds to excess free hemoglobin. 
• Retinol binding protein that binds retinol and delivers it to 
skin and eyes for further utilization. 
• Transcortin and thyroxin for corticosteroids and thyroid 
hormone transport, respectively.  
Immune 
proteins 
• Complement proteins (C1 to C9) that are involved in 
alternative and classical pathway, as well as opsonization in 
which bacteria and pathogens are marked for phagocytosis 
• C reactive peptide, elevated in active inflammation in which 
their production is stimulated by interleukin 6 (IL-6) and 1 
and TNF-alpha. 
Apolipoproteins  • Important for fat, cholesterol, and lipid soluble vitamins 
transport. 
• There are five main categories: 
➢ ApoA: major component of HDL 
➢ ApoB: component of LDL and VLDL 
➢ ApoC: control lipid metabolism 
➢ ApoD: a component of HDL  




The liver is responsible for the production, transport and catabolism of some hormones, such as 
thrombopoietin (which plays an important role in platelet formation),  Insulin-like growth factor 
I (IGF-I) that decreases blood glucose levels, acts on muscle as well as other tissues to stimulate 
amino acid uptake and protein synthesis and stimulates chondrocytes (cartilage cells) 
proliferation for bone growth. Furthermore, angiotensinogen is a pro-hormone released by the 
liver as a  precursor for angiotensin II that is responsible for vasoconstriction of blood vessels 







The liver is considered to play a crucial role in storing glucose, vitamins, and minerals; providing 
all substances when needed.  
➢ Vitamins: 
Vitamin D: it is known that diet provides vitamin D, but the most significant amount is derived 
from our skin. Vitamin D is important for calcium homeostasis, neurodevelopment, bone and 
muscle growth, immunomodulation and regulation of cell growth and replication.   
Vitamin K:  Vitamin K exists in two forms: the natural form which is oxidized known as vitamin 
K epoxide, and the reduced vitamin K hydroquinone. Moreover, this vitamin is an important 
factor for bone growth and wound healing.  
Vitamin A: As other lipid-soluble vitamins, vitamin A, also known as retinol ester, is absorbed 
into the liver in the form of chylomicrons. In the liver, retinol esters are transformed into retinol 
and then bound to retinol binding protein (synthesized in the liver). Furthermore, it can be stored 
in special specialized cells in the space of Disse, called stellate cells, to be used later. 
Vitamin B12: Also known as cobalamin, it is transported to the liver by a specific protein 
produced by the liver itself, called transcobalumin II, then either stored or transported to 
peripheral tissues. In the bone marrow, vitamin B12 is a necessity for erythropoiesis. It is also 
important for DNA synthesis and for maintaining the proper functioning of the nervous system.  
Vitamin E: It is related to antioxidant activities, and immune system support. 
  
➢ Iron storage 
Iron is an important mineral that has an essential role in hemoglobin production, immune 
support, muscle metabolism, brain, and thyroid functioning. At the level of blood Fe2+ binds to 
the plasma protein transferrin where is distributed to be used mainly by muscle tissue and the 
erythroid compartment, or stored in the liver, spleen, and bone marrow . In the liver hepatocytes, 
an intracellular protein known as ferritin serves to store Fe2+ in a non-toxic form. Furthermore, 
a high concentration of Fe2+ in tissues reacts with hydrogen peroxide yielding to Fe3+ and 
hydroxyl radicals OH., a highly reactive oxygen species that can interact with lipids, proteins 
and DNA causing their damage. In this case, hepatocytes can produce a specific hormone known 
as hepcidin that inhibits ferroportin iron transporter at the level of the enterocyte.  
➢ Copper storage 
The essential transition metal copper (Cu) is obtained from dietary sources including  meats, 
shellfish, seeds, and beans. Due to its crucial role in health, it is important to maintain copper 
balance, knowing that the liver is the central regulatory organ of copper homeostasis. Copper is 





most likely bound to albumin and delivered to the liver. In hepatic cells, copper binds to a 
specific protein known as ATP7B and it is used for mitochondrial respiration, radical 
detoxification, and other cellular processes. Copper deficiency  has been linked to many diseases 
such as Alzheimer’s disease, ischemic heart disease, obesity, and non-alcoholic fatty liver 
disease. It was shown that low copper diet induces lipogenic genes expression such as sterol 
regulatory element binding protein-1 (SREBP-1) that is involved in fatty acid synthesis (FAS), 
as well as the decrease of CYP7A1 enzyme, which is a key enzyme in cholesterol degradation. 
Furthermore, CuD downregulates enzymes related to mitochondrial and peroxisomal beta 
oxidation of fatty acids. Other consequences of copper accumulation in tissues are movement 
disorders and brown pigmentation around the eyes. 
 
HEMOPOIETIC FUNCTION  
During fetal life, the liver participates directly in blood cell production. Kupffer cells are 
responsible for the synthesis of erythropoietin hormone, that promotes the production, 
proliferation, differentiation, and maturation of red blood cells. During the postnatal life 
erythropoietin is mainly produced by the kidneys, and the liver contribution to this hormone 
production is between 5-10%. Moreover, normal liver function is essential for hematopoiesis 
due to iron, folic acid, and vitamin B12 supply.  
 
LIVER METABOLISM 
Blood delivered to the liver through the hepatic portal vein is rich in nutrients; glucose, amino 
acids, and fatty acids ready to be metabolized. 
 
HEPATIC GLUGOSE METABOLISM  
Glucose entry to hepatocytes is controlled by the transporter “glucose transporter-2”. Within 
hepatocytes, glucose is phosphorylated into glucose 6-phosphate by hexokinase enzyme with 
adenosine triphosphate (ATP) dephosphorylation into adenosine diphosphate (ADP). Other 
studies showed that this glucokinase accounts for 95 % of the glucose phosphorylation activity 
in cultured hepatocytes. Glucose 6-phosphate may follow three different routes that are 
explained  below (Andany et al., 2016).  
1. Glucose 6 phosphate can be isomerized into glucose 1-phosphate by the 
phosphoglucomutase enzyme. Glucose 1-phosphate then is implicated within the 
glycogen synthesis pathway.  
 
2.    Pentose phosphate pathway: It is an alternative pathway of glycolysis that takes place 
in the cytosol and is considered as an anabolic pathway and not catabolic. Glucose 6-





carbon dioxide with the reduction of NADP+ into NADPH. Gluconolactone is converted 
then oxidized and isomerized into ribulose 5-phosphateribose 5-phosphate or xylulose 
5-phosphate. Ribose 5-phosphate is essential for the synthesis of nucleotides and nucleic 
acid and released NADPH is essential for the synthesis of fatty acids, cholesterol, steroid 
hormones and of two non-essential amino acids (proline and tyrosine) and for the 
reduction of antioxidant enzymes such as glutathione. 
 
3. Glucose 6-phosphate can be reversibly isomerized into fructose 6-phosphate by glucose 
6-phosphate isomerase. Fructose 6-phosphate is involved in two different pathways 
explained below. 
➢ Hexosamine pathway:  
In this pathway fructose 6-phosphate leads to the production of UDP-N-
acetylglucosamine is essential for glycosylation of proteins, lipids, immune 
receptors, immunoglobulins, cytokines, and other molecules that contribute to 
immune system functioning.  
 
➢ Glycolysis:  
Glycolysis is a process that takes place in the cytosol, in which fructose 6-
phosphate undergoes further phosphorylation producing fructose 1,6-
biphosphate that splits into dihydroxyacetone phosphate and glyceraldehyde 
3-phosphate, two reversible trioses. GA3P is then converted into a pyruvate 
molecule in some reactions  producing two pyruvate molecules, two ATP and 
two nicotinamide adenine dinucleotide (NADH) molecules. Pyruvate is 
transported into the mitochondria by pyruvate translocase and decarboxylated 
to produce acetyl-CoA that enters the Krebs cycle (Andany et al., 2016; 
Iynedjian P. et al., 1995).  
 
     Supplementary Box 6: KREBS CYCLE 
Also known as citric acid cycle CAC or tricarboxylic acid cycle, a series of reactions 
that take place in the mitochondrial matrix to produce energy in the form of ATP. Acetyl-
CoA derived from carbohydrates, fats, and proteins metabolism enters Krebs cycle 
where it  is condensed with oxaloacetate to produce a 6-carbon molecule known as citrate 
that is isomerized into isocitrate. The latter is oxidized and decarboxylated into 5-carbon 
α-Ketoglutarate and CO2 by Isocitrate dehydrogenase where NAD
+ is reduced into 
NADH. Then α-Ketoglutarate undergoes another oxidation-decarboxylation reaction by 
α-Ketoglutarate Dehydrogenase producing 4-carbon Succinyl-CoA, NADH molecule, 
and CO2. Succinyl-CoA is converted into succinate by Succinyl-CoA synthetase with 
phosphorylation of guanosine diphosphate (GDP) into guanosine triphosphate (GTP) 
which is equivalent to an ATP molecule. Then succinate is oxidized into fumarate along 
with FAD reduction into FADH2. The product fumarate is hydrolyzed by fumarase 
enzyme to produce L-Malate which is then oxidized by malate dehydrogenase into 





molecule following the Krebs cycle can produce 1 ATP, 3 NADH, and 2 FADH2 




NADH and FADH2 molecules produced from the Krebs cycle in the mitochondrial matrix are 
utilized to produce ATP in a process known as oxidative phosphorylation that involves electron 
flow through the ETC, a series of proteins and electron carriers within the mitochondrial 
membrane. ATP is essential for the function and all the reactions taking place within the cell.  
➢ FADH2 and NADH Delivery: It should be clear that NADH is considered to be more 
electron donating than FADH2 since NADH can transfer its electron into complex I 
where the energy released is used to pump protons from the matrix into the 
intermembrane, while FADH2 is delivered to complex II which cannot pump proton 
across the membrane. This means that FADH2 pumps less protons yielding less ATP 
production.  
➢ Then electrons from both molecules follow the same route, electrons from complex I and 
II are transferred to an electron carrier called ubiquinone (Q). The latter delivers the 
electron to complex III where more protons are pumped into the intermembrane, then 
electrons are transferred to another mobile carrier known as cytochrome C. 
➢ Cytochrome C carries the electrons to complex IX pumping more protons across the 
membrane. At the level of complex IX, in the mitochondrial matrix electrons are 
quenched by oxygen, the final acceptor of ETC,  forming H2O.  At this step the ETC role 
ends, resulting in an electrochemical gradient across the inner mitochondrial by proton 
accumulation within the intermembrane. H+ move down the gradient across the 
membrane by the help of a membrane spanning protein called complex V, also known 
as ATP synthase. As ATP synthase turns, it catalyzes the addition of phosphate group to 
ADP resulting in ATP production. This process by which ATP is produced from a proton 
gradient is known as chemiosmosis (Cardol, 2009).   
 
AMINO ACID METABOLISM 
The liver absorbs up to 60 - 70% of  amino acids present in the portal vein through sodium 
dependent transporters. Amino acid metabolism only accounts for 10 to 15% of our total energy 
production. In the liver amino acids are utilized for the synthesis of liver protein and serum 
proteins, hormones, porphyries, and nucleotides. In case of amino acid excess, some amino 
acids, such as alanine, cysteine, serine, glycine, threonine, and tryptophan can be metabolized 
into pyruvate that follows several routes as explained above. Pyruvate can either undergo 
gluconeogenesis for glucose synthesis or transformed into acetyl-CoA than in turn enters Krebs 







FATTY ACID METABOLISM 
 
Biological lipids are defined as a diversity of chemical groups sharing a common feature, which 
is their insolubility in water. Fatty acid is a carboxylic acid with a hydrocarbon chain of 4 to 36 
carbons, it can be fully saturated with no double bonds, unsaturated with one double bond, and 
with two or more double bonds, known as polyunsaturated fatty acids. Length of hydrocarbon 
chain and the degree of unsaturation determined by a number of double bonds define the physical 
properties of fatty acids, for example as the hydrocarbon chain gets shorter the ability of 
hydrocarbon chains to interact is reduced therefore; the molecules are not tightly packaged and 
the solubility in water increases.  In case of double bonds number increase more kinks in the 
hydrocarbon chains are formed. 
 
➢  FATTY ACID FUNCTIONS 
FAs biological functions are diverse as shown in table 6, fats and oils are considered the principal 
storage form of energy in many organisms, in addition to their role in hormones, pigments, 
cofactors and detergents  synthesis.   
                   










FATTY ACIDS SOURCE, DIGESTION AND UPTAKE  
Cells obtain FAs mainly from three different  sources: dietary fats, lipolysis of FAs stored in 
LDs and de novo lipogenesis where FAs are synthesized from a non-lipid source like 
carbohydrates.  
Function Example 
Energy storage Fatty acids, triglycerides 
Hormones Sex hormones:  estrogen, testosterone  
Adrenal hormones: cortisol, aldosterone 
Electron carriers Ubiquinone (known as coenzyme Q) 
Pigments Retinal  
Messengers Extracellular: eicosanoids 
Intracellular: phosphatidylinositol  
Cofactors Vitamin K 





• DIETARY FATTY ACIDS: 
Concerning dietary FAs, after digestion FAs are emulsified and converted into micelles in the 
small intestine by the action of bile salts stored in the gall bladder. Then intestinal lipases degrade 
these micelles into free molecules of fatty acids and monoglycerides that can diffuse through 
epithelial cells lining intestinal mucosa where they are packaged together with cholesterol and 
apoproteins into chylomicrons. Chylomicrons move through the lymphatic system and 
bloodstream to reach specific tissue; inside the capillary ApoC-II, which is an apoprotein on the 
surface of chylomicrons, activates lipoprotein lipase. The latter hydrolyses triacylglycerols 
allowing the uptake of FFA and glycerol by cells of target tissues.  
  
•   LIPOGENESIS: 
It is a process by which fatty acids are synthesized from acetyl-CoA derived from lipids or 
a non-lipid source such as carbohydrates, which is known as de novo lipogenesis. Fed state, 
high blood glucose level yielding to ATP excess stimulate fatty acid synthesis. Actually, 
high levels of ATP exert a negative feedback on the isocitrate dehydrogenase enzyme thus 
increasing isocitrate concentration which is reversibly converted to citrate. High levels of 
citrate negatively regulate acetyl-CoA from completing the Krebs cycle, and citrate is 
transported to cytoplasm via citrate transport protein (CTP), then broken down into 
oxaloacetate and acetyl-CoA. Produced acetyl-CoA is carboxylated by an important 
enzyme known as acetyl-CoA carboxylase (ACC) into malonyl-CoA.  
  
Acetyl-CoA and malonyl-CoA are the substrates of fatty acid synthesis, but this  requires 
NADPH as a reducing agent provided as discussed above from malic enzyme activity and 
pentose phosphate pathway. Fatty acyl synthetase (FAS) is the enzyme responsible for FA 
synthesis through several repeated reactions. This process takes place in the cytoplasm of 
adipose tissues and the liver mainly. Synthesized fatty acids are cellular key components 
that have essential functions.  
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  Figure 13: Hepatic lipogenesis. Malonyl-CoA is condensed with several acetyl-CoA moieties by 











Fatty acids can be derived from stored fats by lipolysis which is a catabolic process that involves 
the breakdown of fat stored in the form of  TAGs within adipose tissue, where three fatty acid 
chains and a glycerol backbone are formed as products. This process requires three different 
steps, each step liberates one fatty acid chain. 
➢ 1st step: Adipose triglyceride lipase (ATGL) hydrolyses the first bond resulting in one 
FA and a diacylglycerol (DAG). 
➢ 2nd step: second ester bond is cleaved by hormone sensitive lipase (HSL), liberating 
FA and a monoacylglycerol (MAG). 
➢ 3rd step: MAG undergoes hydrolysis by monoglyceride lipase (MGL) releasing its last 
FA and glycerol.  
                                     
 
  




TRIGLYCERIDE SYNTHESIS  
Triglyceride synthesis takes place in the endoplasmic reticulum of cells in an esterification 
process of fatty acids to glycerol. Three fatty acid chains are bonded to each glycerol molecule 





(-COOH). The three fatty acid chains can be of the same kind or of two or more different fatty 
acid types to form simple or mixed triacylglycerol, respectively.  As in fatty acid synthesis, 
triglyceride synthesis can occur in adipose tissue and liver; those synthesized in the liver are 
secreted into the blood in the form of very-low-density lipoproteins (VLDL) to be delivered to 
peripheral tissues.  
 
Supplementary Box 7: LIPOGENESIS AND LIPOLYSIS REGULATION  
ACC enzyme is heavily regulated by two ways: allosteric regulation, where it is 
stimulated by citrate and inhibited by long chain fatty acids, hormonal regulation, as 
insulin can stimulate malonyl-CoA formation through phospho-protein phosphatase that 
dephosphorylates ACC lowering its enzymatic activity, while adrenalin, cortisol and 
glucagon inhibit FA synthesis and trigger lipolysis mediated by protein kinase A (PKA) 
activation, which in turn phosphorylates ACC and inactivates its enzymatic activity.  
Moreover, insulin stimulates pyruvate dehydrogenase which converts pyruvate into 
acetyl-CoA, thus stimulating the lipogenic pathway. Leptin, a hormone released by 
adipocytes, negatively regulates lipogenesis through glucose intake inhibition and down 
regulates the expression of genes involved in fatty acid synthesis. Growth hormone 
prevents the stimulation of lipogenesis through insulin signaling modulation, thereby 
decreasing insulin sensitivity, and down regulating fatty acid synthase expression.  
Lipolysis is triggered by several hormones: adrenalin, cortisol, growth hormone and 
glucagon, which activate adenylyl cyclase to release cyclic adenosine monophosphate 
cAMP; PKA activated by cAMP phosphorylates perilipin (also known as LD-associated 
protein), which in turn stimulates HSL.  
 
 
 FATTY ACID OXIDATION  
 
MITOCHONDRIAL BETA-OXIDATION  
Fatty acid oxidation is the catabolic phase of FA metabolism to generate energy. In a eukaryotic 
cell, FA oxidation takes place mainly within the mitochondria in three steps: removal of 
successive two- carbon units in the form of acetyl-CoA, then acetyl-CoA are oxidized into CO2 
via Krebs cycle and finally products obtained from the first two steps donate electrons to the 
mitochondrial respiratory chain for ATP production. It is called beta oxidation since oxidation 
occurs at β carbon.   
 





   
 SATURATED FATTY ACID:  
The most naturally occurring fatty acids found in various animal and plant fats are with even 
number of carbon atoms such as stearic acid, oleic acid, and palmitic acid. Fatty acid is broken 
into acetyl-CoA in 4 steps, after each cycle acetyl-CoA, FADH2, and NADH molecule are 
produced. After that, FADH2 and NADH electron carriers move to ETC to generate 2 and 3 ATP 
molecules each, respectively. Furthermore, acetyl-CoA enters Krebs cycle to be oxidized into 
CO2 and H2O producing 12 molecules of ATP.   
 
    UNSATURATED FATTY ACID CHAIN  
Oxidation of unsaturated fatty acid requires an additional isomerization step while it does not 
generate as many ATPs molecules produced from saturated fatty acid with the same number of 
carbons. This is explained by the fact that the presence of double bond eliminates the first step 
usually done in saturated fatty acids, which is dehydrogenation for double bond formation, along 
with this step an FADH2 molecule is produces. Thus, for every double bond 2 ATP are less 
formed.  
 
➢ ODD NUMBER OF CARBON FATTY ACID CHAIN   
Fatty acids with odd number of carbon atoms are usually found in the lipids of plants and 
some marine organisms. They are oxidized in the same pathway as the even-carbon acids 
in the beginning, but differ in the substrate for the last step, where a three carbon 
propionyl-CoA is produced. Then propionyl-CoA is carboxylated, converted and 
undergoes intramolecular rearrangement to form succinyl-CoA that can enter the citric 
acid cycle. The difference in terms, succinyl-CoA when oxidized into CO2 and H2O via 
citric acid cycle generate 6 ATP molecule, less than those produced from the last acetyl-
CoA produced from an even-carbon chain.     
 
 
PEROXISOMAL β-OXIDATION  
The major site of fatty acid beta oxidation is mitochondria, but it still can occur in other 
compartments within certain cells. Very long chain fatty acids (longer than 22 Carbons), 
branched fatty acids, and some prostaglandins undergo oxidation inside peroxisomes. 
Peroxisomes are membrane bound organelles that contain enzymes involved in fatty acid 
oxidation, in a slightly different process from mitochondrial β oxidation.  The difference is in 
the first step where FA is oxidized, and one FAD molecule is reduced to FADH2. In 
mitochondrial oxidation electrons are carried by FADH2 into ETC for ATP production while in 





enzyme into H2O and O2).  Subsequent steps are the same as their mitochondrial counterparts. 
Sometimes peroxisomal oxidation is considered as a shortening process where the yielded 
shortened fatty acyl continues its oxidation in the mitochondria.   
 
 
MICROSOMAL OMEGA OXIDATION 
Omega (ω) oxidation is important in some animals, and an alternative pathway in humans when 
defects in  β-oxidation occur. ω-oxidation takes place in the smooth ER of liver and kidney 
instead of the mitochondria and peroxisome , it is involved in the oxidation of medium-chain 
(10-12 carbon atoms). It is called so because ω-carbon (the most distant carbon from the 
carboxyl group) undergoes hydroxylation by P450 where a hydroxyl group (OH) is oxidized to 
produce fatty aldehyde. The latter is oxidized into a carboxylic acid. Thus, a fatty dicarboxylic 
acid with a carboxylic acid at each end is obtained that undergoes several rounds of β-oxidation 
to give acetyl-CoA molecules. It can end also in four carbon chain “succinyl-CoA” which as an 
intermediate in citric acid cycle. Succinyl enzyme also provide substrate for gluconeogenesis 
under starvation or diabetic conditions.  
 
 
ALPHA-OXIDATION OF FATTY ACID  
Another form of fatty acid oxidation is known as alpha-oxidation not common in humans, but 
in other mammals that feed on grasses. α- oxidation is involved in the oxidation of branched 
fatty acids at the beta carbon where the attached group on the beta carbon prevents this fatty acid 
to undergo β-oxidation. α- Carbon is hydroxylated and oxidized, followed by the removal of one 

















Thus, the liver is an important organ with vital and multi-functions, exposed to multiple 
metabolic disorders, toxic substances and microbes leading to disease development. Liver 
disease is defined as any potential disturbance that causes loss of liver function resulting in 
illness. Several diseases can be associated to the liver, some are asymptomatic while others show 
symptoms after weeks, months or even years. For example, cholestasis, in which bile flows are 
obstructed, cell inflammation in case of hepatitis, inadequate blood flow, tissue damage by 
chemicals as well as minerals or due to abnormal cell infiltration such as cancer cells, viral 
infections such as Hepatitis (A, B and E) and steatosis. 
 
STEATOSIS DEFINITION 
It is a pathological process characterized by triglycerides accumulation within the parenchymal 
cells, especially at the level of the liver to end in hepatic steatosis, but it can occur also at the 
level of the heart, kidney, and muscle (Figure 15). The steatotic liver is characterized by an 
increased size, and at the microscopic level by the presence of intracellular lipid droplets.  
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Several factors can lead to steatosis: 
• Toxic substances such as poisons, dyes and ethanol can cause liver toxicity.  
• Metabolic imbalance leading to mitochondrial function impairment. 
•  Diabetes or hyper-lipidic diet  
 
CLASSIFICATIONS OF STEATOSIS 
From a morphological point of view, steatosis is classified into 3 different classes: micro-
vesicular, macro-vesicular and mixed.  
Micro-vesicular steatosis: It is the case where triglycerides accumulate in numerous tiny 
cytoplasmic LDs forming a foamy cytoplasm, and the nucleus remains central. Micro-vesicular 
steatosis is less common but more severe. This pattern is usually associated with disorders of 
mitochondrial β-oxidation leading to decreased synthesis of apoproteins and lower production 
of VLDL  .  
Macro-vesicular steatosis: It is usually the predominant form in which cytoplasmic LDs 
accumulate within a single large vacuole displacing the nucleus to the periphery which leads to 
hepatocyte enlargement. Macro-vesicular steatosis is typically linked to alcohol consumption, 
diabetes, obesity, drug impairment, toxins, and protein malnutrition.  
The third is the mixed droplet pattern (micro-vesicular and macro-vesicular) which has a higher 
risk of progression to cirrhosis than macro-vesicular steatosis. (Stefan G. Hübscher et al., 2018; 
Apica et al., 2014).  
 
Another classification is based on the involvement of alcohol in disease development.  
❖ ALCOHOLIC FATTY LIVER is a pathological condition mainly caused by excessive 
alcohol intake, where alcohol degradation and oxidation yield to acetaldehyde formation 
in a reaction that produces NADH. Further oxidation of the former produces NADH also 
at the mitochondrial level. Increased NADH production stimulates lipid synthesis, 
decreases mitochondrial lipid oxidation, and prevents VLDL release. Furthermore, 
acetaldehyde is a very reactive molecule that can react with the amino groups of proteins 
causing damage and lead to ROS production.  
 









NON-ALCOHOLIC FATTY LIVER DISEASE 
 
DEFINITION  
Another form of steatosis is known as NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). NAFLD, 
was first described in 1980’s as the accumulation of lipids in more than 5% of hepatocytes, in 
the absence of excessive alcohol use or a direct cause for hepatic steatosis. It is a metabolic 
dysfunction associated with a wide spectrum of liver diseases, ranging from simple 
asymptomatic steatosis, also known as NAFLD, that can progress over a 10 years period to non-
alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis, up to hepatocellular carcinoma 
(Lindenmeyer et al., 2018). 
Lipids accumulate in the form of cytosolic Lipid Droplets (LDs) that contain mainly   
triacylglycerol (TAGs). Fat accumulation may be due to:  
i. Increased de novo lipogenesis (DNL) from the non-lipid source like carbohydrates.  
ii. Increased FFAs due to excessive lipolysis or increased dietary fat intake. 
iii. Reduced FFA oxidation. 




EPIDEMIOLOGY   
Studies have reported that NAFLD affects around 25% of the general population and around 3% 
of the pediatric population, knowing that the highest prevalence is in the Middle East and South 
America while the lowest is in Africa. This prevalence is affected by several parameters such as 
body fat distribution and body composition. Moreover, patients with obesity, type 2 diabetes, 
dyslipidemia, and hypertension are at higher risk of NAFLD development compared to control 
groups (Souza et al., 2012).  Previous study showed that NAFLD prevalence increases to 57-
74% and 22 to 58 % in obese adults and children, respectively (Tarantino et al., 2007). It is 
shown that NAFLD prevalence in adolescents is higher than in children, which can be explained 
by several factors including sex hormones and insulin resistance in puberty, in addition to the 
increased unhealthy food choices and changed lifestyle in adolescence. Moreover, NAFLD is 
more common in males than in females which suggests the intervention of estrogens in liver 










A major problem associated with steatosis  is being liver biopsy, the gold standard procedure 
used for diagnosis. This method is invasive and risky due to complications during surgery (such 
as bleeding, pain, and infection), it results in a lot of bias where the biopsy is only a little 
specimen, which limits data attribution to the entire liver status. It is difficult to monitor 
progression to fibrosis since it requires multiple repetitions of the biopsy procedures. 
Several tests and screening methods candidate to provide an alternative approach to replace liver 
biopsy.  
 
BLOOD AND SERUM TESTS  
Since NAFLD is a complex multi-factorial disease, it is difficult to identify a single marker to 
assess hepatic steatosis. Thus, several markers and scores that can provide a good diagnostic 
measurement will be detailed in the table 7 below. These multiple-parametric panels are cost 
effective and not available in all clinical applications.   
 
     Table 7: Parameters tested in NAFLD diagnosis 
                             Panel                       Parameters tested  
NAFLD ridge score ALT, HDL, cholesterol, triglycerides, HbA1c, 
leukocyte count, hypertension 
NAFLD Liver Fat Score (NLFS) Liver fat content, metabolic syndrome, type 2 
diabetes, AST, AST:ALT, fasting insulin level 
Fatty liver index (FLI) BMI, waist circumference, triglycerides, -GT 
Lipid accumulation product (LAP) 
Index 
sex, triglycerides, weight circumference 
 
IMAGING TECHNIQUES 
Thus, several Imaging techniques offer direct evaluation of liver status. We will briefly list 
available Image-based methods for NAFLD diagnosis.  
➢ Ultrasound: It is an imaging method that uses high-frequency sound waves to produce 
images of structures within your body, it was first reported as a diagnostic tool for hepatic 
steatosis in 1981 in patients with the alcohol-related disease. This method analyses 
parenchymal alterations, fatty infiltration, and hepatic veins dilatation. However, the 






➢ Controlled Attenuation Parameter CAP:  It is a non-invasive method for hepatic 
steatosis diagnosis, a novel physical measure based on ultrasonic signals acquired by the 
FibroScan device. Hepatic steatosis is detected in patients with 10% of hepatocyte 
degeneration. CAP application is limited in obese patients since abdominal fat may 
increase the skin to liver distance resulting in overestimation of the CAP data.   
➢ Magnetic Resonance Imaging MRI: It is a medical imaging technique that uses a strong 
magnetic field and does not require ionizing radiation to obtain anatomical pictures and 
illustrate physiological processes within the body. A non-invasive advanced MRI 
technique known as MRI-proton density fat fraction (MRI-PDFF) was developed to 
accurately quantify fat over the entire liver. MRI-PDFF is based on the measurement of 
chemical shifts cause by mobile protons from triglyceride and water, where PDFF  is a 
ratio of the density of mobile protons from triglycerides and the total density of protons 
from mobile triglycerides and mobile water that ranges from 0-100%. PDFF score is 
related to the percentage of cells containing intracellular fat droplets. Even though, MRI- 
based techniques are still not suitable due to high cost and limited availability (Pu et al., 
2019) (Caussy et al., 2018) (Drescher et al., 2019). 
 
PATHOGENESIS. 
Multiple factors involved in NAFLD pathogenesis create a network of interactions that 
participate in pathogenesis mechanism. NAFLD initiates as hepatic triglyceride accumulation, 
considered to be relatively benign condition; then, a second hit increases the susceptibility to 
liver injury mediated by pro-inflammatory cytokines, OS, mitochondrial dysfunction and gut 
endotoxins which can develop into NASH, a severe form of steatosis. This mechanism was 
known over a decade ago as “Two-hit theory” (Giorgio et al., 2013). Recently, a third hit has been 
suggested to be implicated in further pathogenesis, due to inadequate hepatocyte infiltration 
Normally, cell death stimulates the replication of mature hepatocytes to replace dead cells. OS 
associated with NAFLD inhibits mature hepatocytes replication resulting in expansion of the 
hepatic progenitor cell population. The latter differentiates into hepatocyte-like cells that are 
strongly correlated with fibrosis and hepatocellular carcinoma (DOWMAN et al., 2009).  
 
MECHANISMS INVOLVED IN NAFLD PATHOGENESIS.  
As we mentioned above, NAFLD is considered as the hepatic manifestation of Metabolic 
Syndrome (MS) and is highly correlated with obesity, diabetes, insulin resistance and 
cardiovascular risk. Despite being a benign and reversible condition at the first stages, it can 
progress to more severe pathologies such as nonalcoholic steatohepatitis (NASH), fibrosis, 
cirrhosis, and eventually hepatocellular carcinoma (Vecchione et al., 2016) (Mello et al., 2015).  
Several factors have shown a contribution to NAFLD pathology progression, mainly by OS and 
inflammation development such as mitochondrial dysfunction, endoplasmic reticulum (ER), 





➢ MITOCHONDRIAL DYSFUNCTION: earlier studies pointed that primarily NAFLD 
was characterized by the presence of mitochondrial dysfunction. Mitochondrial activities 
including fatty acid β-oxidation and ETC regulate fat homeostasis and energy production 
within hepatocytes. Mitochondrial abnormalities may be due to multiple mechanisms 
ranging from mitochondrial DNA (mtDNA) damage to enzymes imbalance, all detailed in 
the diagram below.  (Deng et  al, 2007).  
 
 







➢ ENDOPLASMIC RETICULUM: In the same way, FFA overload induce ER stress 
illustrated by unfolded and misfolded proteins accumulation in ER lumen, activating a 
specific signaling response “unfolded protein response”, which in turn activates the 
expression of pro-inflammatory genes and suppresses those coding for antioxidant 
enzymes. In addition, ER is a potent source of ROS counting for about the 25% of all 
cellular ROS generation. 
ER lumen is the main site of calcium storage that plays a critical role in ER stress. 
Saturated fatty acids may induce ER calcium store disruption leading to  ETC 
mitochondrial membranes blocking through the formation of permeability transition pores 
for cytochrome C, which finally results  in an increased ROS production and apoptosis 
induction.  
 
➢ PEROXISOMES: Moreover, peroxisomes are implicated in long chain FFA oxidation, 
producing H2O2 as an end-product, which means an additional source of radicals. This 
oxidative process may result in  lipid peroxidation that in turn activates Kupffer cells to 
release inflammatory cytokines such as TNF-α and IL-6. All together aid in NAFLD 
pathogenesis and its progression to NASH. (Ucar et al., 2013) (Masarone et al., 2018).  
 
➢ ENDOTHELIAL DYSFUNCTION (ED): Inducible isoform of nitric oxide synthase 
(iNOS) is upregulated  under stress conditions through proinflammatory cytokines (TNF-
α, IL1, and interferon gamma IFN-γ) that are upregulated also in obesity and insulin 
resistance. iNOS overexpression that contributes also for ED leads to  high amounts of NO  
that are involved in several inflammatory and autoimmune diseases. Impaired generation 
of NO has been shown to promote the production on superoxide and hydroxyl radical 
intermediates increasing OS state. Altogether, it  explains the role of  ED in  
pathophysiological progression.  
 
➢ INSULIN RESISTANCE (IR): IR is a major factor implicated in NAFLD and MS 
pathogenesis. In the case of IR within the liver, suppression of hepatic glucose production 
by insulin is reduced and synthesis of apolipoprotein B-100 is decreased, while hepatic 
synthesis of FFAs is increased, all leading to triglyceride accumulation in the liver. Thus, 
IR is correlated to increased FFA flux as a result of lipolysis suppression; since FFAs can 
directly cause toxicity by triggering OS and inflammatory pathways, they are accumulated 
in the form of triglyceride as a protective mechanism to avoid toxicity. Furthermore, FFAs 




➢ GUT-LIVER AXIS: Bacterial population hosted in adult human intestine is enormous, 
almost around 100 trillion, variable and dynamic during human life, being influenced by 





microbiota has several functions, including digestion of otherwise inaccessible nutrients, 
vitamin synthesis, and resistance to colonization by pathogens. However, any 
modifications (either quantitative or qualitative) of “normal” gut microbiota, also known 
as dysbiosis, may be involved in the development and pathogenesis of NAFLD and other 
metabolic diseases. Thus, the new concept of gut-liver axis involvement in NAFLD 
progression refers to the interaction between the liver, the intestinal barrier, and the gut 
microbiota. An unbalanced diet, particularly rich in fats and fructose, may lead to dysbiosis 
and intestinal barrier impairment, which favors metabolic endotoxemia and low-grade 
inflammation.  It’s known that intestinal dysbiosis may affect energy intake and whole-
body metabolism. Microbiota-derived metabolites, namely Short Chain Fatty Acids 
(SCFAs), are known to be both a source of energy, particularly for colonocytes, and 
signaling molecules able to interfere with the host metabolism at different levels, 
comprising the regulation of de novo lipogenesis. Moreover, different strains of gut 
bacteria can produce other metabolites such as neurotransmitters, neuropeptides which can 
interfere with the mechanism regulating energy homeostasis and food intake. 
Immunological and inflammatory signaling deriving from the disruption of the integrity 
of the intestinal barrier (the so-called “leaky gut”) may be part of the hits that trigger the 
worsening of simple steatosis to steatohepatitis and further liver damages. Interestingly, 
germ-free animals seem to be resistant to diet-induced obesity, liver steatosis and insulin 
resistance. When these animals are transplanted with a microbiota from a healthy donor, 
the hepatic TAG content is doubled. When the donor for microbiota transplantation suffer 
from NAFLD, this phenotype is replicated in wild-type recipients. Previous studies stated  
the association of some microbial strains with NAFLD phenotype in mice, for example 
Lachnospiraceae bacterium 609 and a relative of Barnesiella intestinihominis (Bäckhed et 




GENES REGULATING LIPID HOMEOSTASIS  
Biological processes are regulated by several genes, for example lipid homeostasis is controlled 
by a panel of genes regulating either lipogenesis or lipolysis.  
1. Peroxisome Proliferated Activated Receptors (PPARs): PPARs were originally named 
for the ability of ligands to induce hepatic peroxisome proliferation, which is a phenomenon 
specific to rodents (Issemann et al., 1990). PPARs are the most known genes implicated in 
lipid homeostasis. PPARs are ligand-activated transcription factors activated by different 
FAs, naturally occurring FA-derived molecules and synthetic compounds. They share 
common structural features that include an amino-terminal domain, DNA binding domain 
and a carboxyl-terminal ligand binding domain. Once activated by an endogenous or 
exogenous ligand, PPARs form a heterodimer with retinoid X receptor and bind peroxisome 
proliferator response elements  that regulate the expression of a panel of genes encoding 
enzyme and proteins implicated in beta oxidation, fatty acid uptake, adipogenesis, adipocyte 





tumorigenesis and inflammation (Varga et al., 2011). There are three different isoforms for 
PPARs, differentially expressed in various tissues.  
 
➢ PPARα in humans is expressed equally among most tissues with higher expression in liver, 
kidney, heart, muscle, and adipose tissue. This isoform has a critical role in metabolism 
regulation as it induces the expression of proteins involved in FA uptake, trafficking, and 
oxidation (β and ω-oxidation) as well as in glucose uptake. Furthermore, it exerts anti-
inflammatory effect through NF-kB  pathway regulation.  
➢ PPARϒ is the second isoform of PPARs, highly expressed in adipose tissue and induced 
mainly when energy storage is required. It has a crucial role in regulating  adipocyte 
differentiation, adipogenesis, and lipid metabolism in which it is implicated in the anabolic 
esterification of FAs to TAGs and activation of adipogenic gene expression program, 
leading to accumulation of lipid storage within the liver. PPARϒ overexpression  is a main 
feature of steatotic liver in which its expression was observed to be upregulated in all 
experimental models.   
➢ PPARβ, also known as PPARδ, is expressed in gastrointestinal tract, kidneys, skin, adipose 
tissue; PPARβ is well expressed in hepatocytes, in addition to its presence in Kupffer cells 
and hepatic stellate cells, which explains the role in inflammation and fibrosis. Even if the 
role of this PPAR is still unclear in NAFLD progression, it has been shown that PPARβ 
expression ameliorate hepatic steatosis and inflammation by promoting hepatic FA 
oxidation (Vergani et al., 2017).  
As shown in Table 8 due to the critical role that PPARs have in regulating lipid and glucose 
metabolism, several studies have targeted this family of nuclear receptors for drug 
development aimed to treat metabolic diseases including NAFLD. ((Grasselli et al., 2017) 
(Liss et al., 2017) 
 
LIPID DROPLET ASSOCIATED PROTEINS 
 In mammals, excess lipids are stored in the form of triglycerides within LDs that are present in 
adipose tissue, hepatocytes, heart, and skeletal monocytes. Several models for LD biosynthesis 
have been suggested by Walther and Farese, and the most accepted model is that triglyceride 
accumulated at the ER membranes bud and form a vesicle that increases by size via LD fusion 
(Farese et al., 2009). Thus, LD structure is composed of a neutral lipid core, which consists 
mainly of triacylglycerols (TAGs) and cholesterol esters, surrounded by a phospholipid 
monolayer  decorated by several structural and functional proteins. The most studied group of 
LD-associated proteins are known as the PLINs family that comprises several members detailed 
below. Despite the sequence difference among PLINs, they all share a common feature that is 
coating LD surface with a main function  to regulate LD metabolism by recruiting lipases and 
other proteins to LD surface which enhances lipolysis thus increasing FA and glycerol 
concentrations. 
➢ PLIN1: known as perilipin, expressed in hepatocytes isolated from humans, while it was 
absent in normal and steatotic livers of mice. The most studied role of PLIN1 is the control 





synchronized with a key regulator of de novo lipogenesis known as sterol regulatory 
element-binding protein (SREBP)-1c.  
➢ PLIN2: was originally named as adipose differentiation-related protein (ADRP) due to its 
high expression during adipocyte differentiation. PLIN2 in expressed in human and 
murine liver. PLIN2 promotes TAG accumulation, inhibits FA oxidation, increases insulin 
resistance, and impairs glucose tolerance. PLIN2 polymorphism in NAFLD patients was 
linked to decreased VLDL secretion. Previously, Imai et al showed that antisense 
oligonucleotide against ADRP reduced steatosis and VLDL secretion, and enhanced 
hepatic insulin sensitivity in ob/ob and diet-induced obese mice (Imai et al., 2007) 
Furthermore, PLIN2 knock-out mice were protected from hepatic steatosis when fed with 
a high fat diet.  
➢ PLIN3: also named as tail-interacting protein of 47 kDa (TIP-47) that is ubiquitously 
expressed among tissues. TIP-47 and ADRP are the major LD proteins in hepatocytes.  It 
has been identified in human and mouse liver, as well as in rat hepatocytes. PLIN3 has 
shown to be upregulated in the liver of HFD-fed mice. Another study showed that  the use 
of PLIN3 anti-sense oligonucleotide in mice reduces hepatic TAGs and improves insulin 
sensitivity (Carr et al., 2011). 
➢ PLIN4:  originally called S3–12. This protein is present at cytosol and LDs. PLIN4 knock-
out mice showed a significant reduction of TAG content in heart tissue.  
➢ PLIN5: known as oxidative tissue-enriched PAT protein (OXPAT), has been widely 
documented in human and mouse protein, as in rat hepatocytes. PLIN5 expression is 
increased in fatty livers of dystrophic mice, plays a crucial role in regulating cellular FA 
oxidation and stabilizes LDs. Moreover, PLIN5 knock-out mice were from hepatic 
steatosis by increased lipolysis and FA oxidation.   
Genes coding for LD- associated PLINs are under the control of different transcription 
factors such as PPARS. Especially PPARϒ that appears to regulate the expression of 
PLIN1, PLIN2, PLIN4 and PLIN5. (Grasselli et al., 2017) (Minehira et al., 2017).  
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  Supplementary box 8:  Definitions  
 
❖ Methionine/Choline Deficient Diet (MCD) mice: A well-accepted NAFLD model, 
based on the deficiency of two essential amino acids: methionine and choline; essential 
elements for hepatic mitochondrial β-oxidation (VLDL) synthesis (Anstee et al., 
2006).  (Choline for VLDL secretion and methionine for regulatory enzyme activity) 
❖ Humanized APOE2 knock-in (APOE2KI) mouse fed with a high fat diet, a model that 
has a markedly reduced affinity for the LDL receptor, leading to hyperlipidemia. 
❖ Fenofibrates are a part of a drug class known as fibrates; a medication used to treat 
abnormal lipid levels by activating PPARα.   
❖ OLETF (Otsuka Long Evans Tokushima Fatty) rat is a model of non-insulin dependent 











2. GENES INVOLVED IN FA OXIDATION: As explained above, PPARα plays a critical 
role in regulation of lipid mitochondrial β-oxidation that in turn activates the expression of 
PPARα-target genes involved in lipid catabolism such as:  
 
➢ Carnitine-palmitoyltransferase-1 (CPT-1), which is an enzyme in the outer mitochondrial 
membrane considered as rate limiting step in long chain fatty acid oxidation. Long chain 
fatty acids, unlike short chain fatty acids that diffuse freely through mitochondrial inner 
membrane, require transport shuttle system to be transported into the mitochondrial 
matrix. CPT-1 as we said is the first component of carnitine palmitoyltransferase system, 
catalyzing the transfer of the acyl group from coenzyme A to carnitine to form 
acylcarnitine. A translocase then shuttles the acyl carnitine across the inner mitochondrial 
membrane ensuring its entrance into the mitochondrial matrix (Grasselli et al., 2016). 
 
➢ Another alternative pathway for FA metabolism is ω-oxidation controlled by several 
microsomal cytochromes P450, mainly CYP2E1 and CYP4A1 detailed above . In 
addition, exocytosis is a way for TAGs secretion; in which they are packaged with 
apoprotein B (ApoB); the primary apolipoprotein component of VLDL (Grasselli et al., 
























In this study, we aimed to investigate the antioxidant and anti-steatotic effects of FUCs purified 
from C. compressa, F. hermonis, and E. globulus. To this aim, we used two in vitro model 
consisting of rat hepatoma FaO and HECV cells exposed to an oleate/palmitate mixture or H2O2 
for steatosis and OS induction, respectively.   
 
➢ Cytotoxic effect of FUC 
➢ Quantifying ROS production  
➢ TAG content quantification 
➢ Regulation of lipid metabolism genes expression  






















CELL CULTURE AND TREATMENTS 
FaO Cells 
FaO cell line (European Collection of Authenticated Cell Cultures, Sigma-Aldrich) are cells of 
rat hepatoma that grow adherent to the growth surface. FaO cells are widely used as a cellular 
model to mimic liver function as they maintain hepatocyte-specific markers and liver functions 
including VLDL secretion. Cells were grown in Coon’s modified Ham’s F12 medium 
supplemented with L-Glutamine and 10% fetal bovine serum (FBS) with a low glucose 
concentration and incubated in a humidified atmosphere with 5% CO2 at 37°C.  
Prior to the experiment by 24 hours, cells were incubated in with F-12 with 10% FBS and 1% 
glucose 1X (HGC) to supply more glucose for cell growth and TAG synthesis.  
To induce intracellular lipid accumulation and mimic hepatic steatosis and endothelial damage, 
FaO cells were treated for 3 h with a mixture of fatty acids oleate/palmitate (OP) to form steatotic 
cells at a final concentration of 0.75 mM (2:1 molar ratio; which means 0.5 mM for oleate and 
0.25 for palmitate) (Grasselli et al. 2017, Vergani et al., 2017). All treatments (both OP and FUC 
treatment) were performed in F-12 medium deprived from FBS but supplied with 1% glucose 
and 0.25% of BSA. 
 
HECV Cells 
HECV cells are endothelial cells isolated from the umbilical vein that grow also in an adherent 
way. Endothelial cells are used as a model for endothelial damage which is a main metabolic 
abnormal characteristic observed in NAFLD. The culture medium used for the HECV growth is 
DMEM (Dulbecco's modified minimum essential medium) with 10% FBS  and 1% L-glutamine, 
incubated at 37°C, 5% CO2.   
To mimic in vitro effect of a high fat diet and induce steatosis, HECV cells were treated as FaO 
cells with OP mixture using the same concentration.  






Fucoidan were purified as previously explained. The aqueous stock  solution of 1 mg/mL was 
prepared diluted in the proper treatment culture medium to the desired working concentration. 




Cell viability was estimated using a colorimetric test is known as the 3-(4,5-dimethylthiazol-
2yl)-2,5-diphenyltetrazolium bromide (MTT) assay, which is based on the reduction of the 
yellow tetrazolium MTT into purple formazan crystals by metabolically active and alive cells. 
Cells were seeded in 96-well plates and cultured to sub-confluence. At the end of the different 
treatments, cells were incubated for 3 h with 0.5 mg/mL MTT. After discarding the supernatant, 
formazan crystals in each well were dissolved by acidified isopropanol (0.04N HCl in 2-
propanol). Results were obtained by reading the absorbance at 570 nm in a Varian Cary 50 UV-
VIS spectrophotometer.  
According to Lambert-Beer’s law, absorbance value is directly proportional to the concentration 
which is cell viability. Control (untreated) cells were considered to represent 100% viability, 









    
       Figure 17: MTT cell viability assay steps.  
 
 














❖ Varian Cary 50 UV-VIS spectrophotometer 
The spectrophotometer is a crucial instrument used in most of the research fields; biological, 
chemical, clinical, and environmental used for quantitative substance measurement. Its 













                      Figure 18: Representative Diagram of a simple UV-Visible Spectrophotometer.  
 
 
LIGHT SOURCE: that should be stable during the measurement 
and provide intensity and adequate amount of energy   
CUVETTES: are containers where the solution is placed to 
determine the absorbance; can be made from quartz or silica 
MONOCHROMATOR: functions to separate the light into 
component wavelengths  
DETECTOR: transform output of the spectrometer into an 






➢ Effect of FUC on FaO cell viability 
FUCs were tested for their cytotoxic effect on FaO cells, both steatotic and normal. 20,000 
FaO cells per well were seeded in 96 well plate, 200µl/well, and incubated for 24 h to 
grow. For steatotic cells, cells were treated with OP for 3h prior to FUC treatment.   
 
 
➢ Effect of FUC on FaO cell viability 
Cytotoxic effects of FUC on HECV cell viability was measured by MTT assay. 15,000 
HECV cell per well were seeded in 96 well plate for 24 h, then treated with FUC for 










➢ Protective effect of FUC against H2O2 treated cells.  
Another MTT assay was performed to check the protective effect of FUCs against 
hydrogen peroxide (H2O2) induced OS in both FaO and HECV cells. Sub-confluent cells 
were treated with 50 µg/mL of FUCs for 24 h. Then, the medium was replaced by new 
medium containing H2O2 (1 mM) and left for 2 h. MTT was added and results were 
recorded as previously explained (Xie et al., 2015).  
 




QUANTIFICATION OF TRIGLYCERIDES (TAGs) 
FUC anti-steatotic activity was tested by TAG quantification using the “Triglycerides liquid” 
kit after their extraction in chloroform/methanol (2:1) (Sentinel, Milan, Italy). FaO cells were 
grown as previously explained, incubated for 24 hours to reach sub-confluence. Then steatosis 
was induced by OP treatment followed by FUC treatment.  
This assay is based on the principle of triglyceride hydrolysis by lipoproteinlipase (LPL) to 
glycerol and fatty acids; glycerol is phosphorilized to glycerol-3-phosphate in the presence of 
glycerolkinase (GK) and adenosine 5-triphosphate (ATP) and then converted by glycerol-3-
phosphate oxidase (GPO) into dihydroxy-acetone-phosphate and hydrogen peroxide. In the 
presence of hydrogen peroxide, peroxidase (POD) oxidizes the chromagen 4-amino antipyrine 
and TOOS to form a red compound which color intensity is proportional to the concentration 
of an analyte in the sample. The used kit contains all the enzymes required for this hydrolysis, 






Figure 19: Principle of “Triglyceride kit”. Compound represented in pink color are all 
reagents within the kit. 
 
EXPERIMENTAL SETUP.  
1. After treatment of the steatotic (OP) cells with FUC for 24 h, the medium was removed 
and stored for extracellular TAG measurement.  
2. Cells were washed twice with 3 ml of non-sterile phosphate-buffered saline PBS 1X 
solution 
3. Add 3 ml of PBS  1X, scrape the cells and transfer to 15 ml falcon tube.  
4. Centrifuge at 720×g , 4 °C for 10’. 
5. Discard the supernatant and resuspend the cells in 1 ml of PBS.  
6. Transfer to an Eppendorf and centrifuge at 845×g , 4°C for 10’. 
7. Discard the supernatant, add 300 µl of PBS to the pellet and lyse cells using a gauge needle. 
8. The measurements of TAG for every treatment are done in triplicates; in a TAG specific 
Eppendorf put 250 µl of methanol and then add 70 µl of cells. 
9. Add 500 µl of chloroform, vortex for 1 h and then add 250 µl of H2O. 





11. Remove the upper phase (methanol that contains salts, carbohydrates, and some proteins), 
quantify the volume of the lower phase (which contains extracted lipids), and keep 
overnight under the hood for chloroform evaporation.  
12. The next day, add 600 µl of “triglyceride kit”, incubate for 15’ at 37 °C. 
13. Results were obtained by reading the absorbance at 546 nm.  
 
Recorded absorbance should be compared to a standard, for this we did a series of glycerol 
concentrations as TAG standard. Glycerol stock solution was diluted to obtain a final 
concentration of 1.24839 mg/ml. which was used diluted to obtain the standards listed in the 
Table 9.   
 
Table 9: Concentrations of glycerol standard for TAG quantification. Volumes in µl.  
Concentration Volume of glycerol  
(1.24839 mg/ml) 
Volume of H2O  Total volume 
0.13  20  180  200  
0.063  20  380  400  
0.031  20  780  800  
0.025  20  980  1000  
0.017  20  1480  1500  
0.013  20  1980  2000  
0.007  20  3980  4000  
0.0035  20  7980  8000  
 
14. From each glycerol concentration, take 10 µl and put in a TAG Eppendorf, add 590 µl of  
“triglyceride kit”, incubate for 15’ at 37 °C. 
15. Results were obtained by reading the absorbance at 546 nm. (Grasselli et al., 2014) 
(Grasselli et al., 2011). 
 
Values were normalized to protein content as measured by Bradford assay (detailed below) and 
data are expressed as percent TAG content relative to controls.  
 
Extracellular TAG content 










BRADFORD ASSAY  
TAG measurements were normalized to protein concentration to overcome the differences in 
cell number among treatments. For this, proteins were quantified by Bradford assay, which is 
based on the binding of protein molecules to Coomassie dye under acidic conditions, resulting 
in a shift in maximum absorbance from 465 to 595 nm.  
 
    
Bradford reagent preparation:  
1. Weigh 0.003 grams of comassie G-250.  
2. Add 2.4 ml of absolute ethanol and vortex. 
4. Add 5 ml of phosphoric acid and vortex. 
6. Complete the volume to 50 ml by milli-Q H2O.  
 
BSA (0.1 mg/ml) was used to prepare a standard for protein quantification as indicated in the 
table. 
 
Table 10: Preparation of BSA concentrations used for protein quantification. 
BSA standard Volume H2O μl  Volume BSA in μl  




B0  100  0  1  
B10  90  10  1  
B20  80  20  1  
B40  60  40  1  
B80  20  80  1  
 
For cellular protein quantification, cell lysate was diluted 1:5. Two measurements were done for 
Bradford assay, named sample 10 and sample 20 which means 10 μl or 20 μl of diluted sample 
mixed  to 90 μl and 80 μl of H2O, respectively. Followed by the addition of  
Samples and standard were incubated for 15’ in dark with  1 ml of Bradford reagent. Absorbance 
was read at 595 nm. (Bradford, 1976). 
 
BODIPY STAINING 
BODIPY 493/503 is a lipophilic fluorescent probe with its nonpolar structure used for neutral 





then steatosis was induced by OP incubation followed by FUC treatment to monitor their effect 
on intracellular LDs (Grandl and Schmitz, 2010).  
 
Qualitative lipid droplet analysis 
After treatment cells were rinsed three times with non-sterile PBS 1X, fixed with 4% 




Neutral lipids were stained with BODIPY as follow: 
1. Incubation with 1 μg/mL BODIPY 493/503 (Molecular Probes, Life technologies, 
Monza, Italy) prepared in PBS for 30 min. 
2.  Wash with PBS (3 times). 
3.  After neutral lipids staining, nuclei were stained with 4′,6-diamidino-2-phenylindole 
(DAPI, 5 μg/mL, (ProLong Gold medium with DAPI; Invitrogen) which is a fluorescent 
stain that binds strongly to adenine – thymine -rich regions in DNA.  
 
Mounted slides were examined at 10X magnification by Olympus IX53 light microscope 
(Olympus, Milano, Italy), equipped with the standard epifluorescence filter set up. 
Representative images were captured with a CCD UC30 camera and a digital image acquisition 
software (CellSens Entry). 
Quantitative lipid droplet analysis  
For quantitative lipid measurement using BODIPY staining, the same experiment was done in 
96 well plate, where cells were seeded, treated, and stained with BODIPY and DAPI. Results 
were obtained fluorometrically in a LS50B fluorimeter (Perkin Elmer, USA) at 25 °C using a 




ROS (mainly H2O2) production was quantified based on the oxidation of the cell-permeant 2′-
7′ dichlorofluorescin diacetate (DCF-DA, Fluka, Germany) to 2′-7′dichlorofluorescein (DCF). 
Stock solution of DCF-DA (10 mM in DMSO) was prepared and stored at −20°C in the dark.  
➢ QUANTITATIVE ANALYSIS 
  
 FAO CELLS: At the end of treatments FaO cells were scraped and centrifuged at  300×g  rpm 
for 10’ at 4°C. The supernatant was discarded and cells were resuspended in 1 ml PBS-1X and 
incubated for 30’ in dark with  1 µl of DCF-DA stock solution (prepared in DMSO at a 





and the fluorescence was measured fluorometrically (λex = 495 nm; λem = 525 nm) (Halliwell 
et al., 2004). All measurements were performed in a LS50B fluorimeter (Perkin Elmer, USA) 
at 25 °C using a water-thermostated cuvette holder. Results were normalized for total proteins 
(Bradford, 1976).   
  
  HECV CELLS: ROS production was measured as described by Rottmann et al. with slight 
modifications. Cells were seeded in 96 well plate for 24 hours, then treated with FUC for 
another 24 hours. After FUC treatment, OS was induced by H2O2 (0.5 mM for 30’). Cells were 
stained with DCF for 10’ in the dark and washed three times in PBS-1X. Results were recorded 
fluorometrically with excitation wavelength at 485 nm and emission at 530 nm (Rottmann et 
al., 2002).    
 
➢ QUALITATIVE ANALYSIS  
HECV cells: The same principle of DCF was used to qualitatively evaluate ROS production 
using a fluorescent microscope. In a 24 well plate, 40,000 cell/well were seeded for 24 hours, 
then treated with FUC purified from different species for 24 hours. At the end of the treatment, 
cells were treated cells were incubated with 1 mM H2O2 solution prepared in DMEM medium 
for 10 min. After that cells were stained with DCF for 10 min, washed 4 times with PBS1X, 
and images were recorded at the same spot both in the visible and in the fluorescence. The time 
as the fluorescence exposure was the same for all  at 150 ms. Cells were examined by Olympus 
IX53 light microscope (Olympus, Milano, Italy), equipped with the standard epifluorescence 
filter set up. Representative images were captured with a CCD UC30 camera and a digital 








Figure 20: DCF assay based on the oxidation of DCF-DA by ROS (mainly H2O2) into a 
fluorescent DCF molecule.  
 
RNA EXTRACTION AND QUANTITATIVE REAL-TIME PCR 
The effect of FUC treatment at the molecular was tested by monitoring the expression of genes 
implicated in lipid metabolism regulation. For this, quantitative polymerase chain reaction 
DCF-DA 
DCF-DA 







(qPCR) analysis was used, also known as real-time PCR or quantitative real-time PCR. It  is a 
PCR-based technique that correlates amplification of a target DNA sequence with quantification 
of the concentration of that DNA species in the reaction.  
Gene expression analysis requires several steps: 
• RNA EXTRACTION 
• REVERSE TRANSCRIPTION 
• REAL-TIME PCR 
 
RNA EXTRACTION: Total RNA was extracted using Trizol Reagent (Sigma-Aldrich) 
according to the manufacturer’s instructions.   
➢ Cells were scrapped in PBS-1X as previously explained and the cell pellet was 
resuspended in 1 ml of Trizol reagent for 5’ at room temperature 
➢ Add 200 µl of chloroform, vortex and wait for 15’. 
➢ Centrifuge at 12400×g , 4 °C for 15’. Three phases are obtained: the upper aqueous 
phase containing RNA, the intermediate white phase which contains DNA, and the 
lower pink phase  containing proteins. 
➢ Add to the RNA containing phase 500 µl of isopropanol, vortex and wait for 10’. 
➢ Centrifuge at 12400×g, 4 °C for 10’ to get RNA pellet and wash with 1 ml of 75% 
ethanol.  
➢ Centrifuge at 4800×g , 4 °C for 5’; discard the supernatant and wait for ethanol 
evaporation. 
➢ Store in 20 µl of  Diethyl pyrocarbonate (DEPC) water.  
Nanodrop was used to quantify extracted RNA in (ng/µl) and test the purity by measuring the 
ratio (260/280) of absorbance at 260/280 nm.  
 
REVERSE TRANSCRIPTION RT: it is an enzyme-mediated synthesis of a DNA molecule 
using RNA as template. The resulting DNA is known as complementary DNA (cDNA). RT is 
done also in 2 main separate steps. 
The first step is required to denature RNA from its secondary structure and  anneal polyA of 
mRNA to the PolyT primer. For this,  10 µl of a mixture of PolyT (1μl), RNA sample (volume 
corresponding to 1μg) and Rnase free H2O were denatured for 5’ at 70 °C and then held at 4 
°C.   
In the next step,  each mRNA sample is mixed with RT mix that contains Buffer 4 μl, H2O 
3.5μl, DNTPs 1 μl, RNase inhibitor 0.5 μl, and 1 μl  of RevertAid H-Minus M-MuLV Reverse 
Transcriptase (Fermentas, Hannover, MD, USA) . PCR elongation step was triggered by 
running the machine on 42 °C for 1 h and then on 72 °C for 10’ so that the polymerase enzyme 
is inactivated (Grasselli et al., 2016).  






Real-time quantitative (qPCR) reactions were performed in triplicate in a final volume of 15 
μl using 2X SybrGreen SuperMix and Chromo4TM System apparatus (Biorad, Monza, Italy) 
as previously described (Grasselli et al., 2012).  Amplification conditions were as follows: 3 
min at 95 °C, followed by 5 s at 95 °C and 1 min at 60 °C or 64°C for 40 cycles. A melting 
curve of qPCR products (65–94◦C) was also performed to ensure the absence of artifacts. The 
relative quantity of target mRNA was calculated by the comparative CT method using 
glyceraldehyde 3-phosphate dehydrogenase  as housekeeping gene and expressed as fold 
induction with respect to controls (Pfaffl, 2001). 
 



































           MEASUREMENT OF NITRITE/NITRATE (NOx) LEVELS  
As Nitric Oxide (NO) has a short half-life, its production was measured indirectly by its end 
products: nitrites and nitrates (collectively referred as NOx), using the Griess reaction (Green 
et al., 1982). NOx accumulation in cell culture media was calculated against a standard curve 
of sodium nitrite (NaNO2) and normalized by protein content (μmol NaNO2/mg sample 
protein). All spectrophotometric analyses were carried out at 25 °C recording absorbance at 
540 nm with a Varian Cary 50 UV-VIS spectrophotometer.  
The principle of this assay is based on the enzymatic conversion of nitrate to nitrite by nitrate 
reductase. In acidic medium, nitrite reacts with sulfanilic acid (a component of Griess reagent) 
to produce the diazonium ion. The ion is then coupled to the other main component of the 
reagent; N-(1-naphthyl) ethylenediamine to form the chromophoric azo-derivative which 
absorbs light at 540 nm.  
 
 
Figure 21: The mechanism for the nitrite, sulfanilamide, and NED reaction to form 
Azo compound in the presence of NO2.  
 
NO production was stimulated in HECV cells in two different ways:  
1. HECV cells were incubated  with OP for 3 h.  
2. HECV cells were incubated with 25 μM H2O2 for 24h  







           Table 12: Griess reagent preparation.   
Sulfanilamide   (in grams) 0.5 
N-(1-naphthyl) 
Ethylenediamine (in grams) 
0.05 
Phosphoric Acid (volume in ml)  2.94 
H2O (total volume in ml) 50 
 
EXPERIMENTAL PROTOCOL 
1. After FUC treatment, culture medium was collected and centrifuged at 16900×g for 10’ 
at 4 °C, whilst the cells were scrapped and tested for protein quantification using 
Bradford assay. 
2. 400 µl of the supernatant were incubated with 400 µl of Griess reagent for 10’ in dark at 
room temperature. 
3.  Sodium nitrate (NaNO2) stock solution (30 mM) was used to prepare a standard for 
values comparison ( 500 µM,   50 µM, 10 µM, 5 µM and 1 µM) 
























FaO CELLS (rat hepatoma cell line) 
 
                   ANTIOXIDANT EFFECTS in FaO CELLS 
 
Cell Viability 
Results of MTT assay demonstrated that purified FUC tested at different concentrations (12.5-
100 μg/mL) did not affect cell viability both in the absence and in the presence of OP.  The 
intermediate concentration 50 μg/mL of CYS, FER, and EUC was selected for further 
experiments. 
MTT assay was used also to test cell viability in FaO cells pretreated with CYS, FER or EUC 
for 24 h and subsequently with 1 mM H2O2 for 2 h to induce oxidative cell damage. As shown 
in Figure 22B, 1mM H2O2 alone/ in the absence of FUC significantly reduced cell viability by 
38% (p ≤ 0.001 with respect to control), whereas FUC pretreatment prevented this decrease in 
a significant way only for FER, and EUC (p ≤ 0.01 with respect to H2O2) in which cell viability 























































Figure 22: MTT assay results on FaO cells; A: control and steatotic FaO Cells;  B: control 
and H2O2 treated FaO cells). ***p ≤ 0.001 with respect to control; ## p ≤ 0.01 with respect 




ROS PRODUCTION  
The principle of the cell-permeant 2′-7′ dichlorofluorescin diacetate oxidation to 2′-
7′dichlorofluorescein (DCF) is used for quantifying in situ the production of H2O2 and other 
ROS. Antioxidant potential of FUC was confirmed by DCF assay for ROS detection in  
steatotic FaO cells (Figure  23). OP treatment resulted in a significant increase in ROS 
production (+ 30%, p ≤ 0.01 with respect to control), while ROS production was decreased in 
steatotic FaO cells after FUC treatment: 
➢ Slight decrease with CYS treatment (8.6 % compared to OP).  
➢ Significant decrease with FER (by 55.9 %)  and EUC (by 64.2 %) with respect to OP 







































ANTI-STEATOTIC EFFECTS ON FaO CELLS 
 
Spectrophotometrical analysis  
Intracellular TAG content was quantified in both control (C) and steatotic cells in absence (OP) 
or presence of FUC (CYS, FER or EUC). Results reported in figure 24A indicated that OP 
treatment significantly increased TAG content with respect to control (+175%; p ≤ 0.001) as 
previously described (Grasselli et al., 2011). However, incubation with 50 μg/ml of CYS, FER 
or EUC after OP treatment decreased TAG content by 35%, 36% and 56%, respectively as 
compared to OP (p ≤ 0.01 for CYS and FER; p ≤ 0.001 for EUC) (Fig 24A).   
 
Extracellular TAG content in cell culture medium was measured as an indication of TAG 
secretion by FaO cells. Figure 24B shows that TAG secretion was significantly increased in OP 
cells with respect to control (+40%, p ≤ 0.01), and subsequent CYS or FER treatment did not 
cause any significant change in TAG content while EUC treatment enhanced its secretion in a 



































Figure 23: Results of ROS production  in steatotic FaO cells measured by DCF assay. 









Figure 24: TAG content quantification in FaO cells. (A: Intracellular TAG; B: Extracellular TAG). 




BODIPY STAINING   
Lipid lowering property of FUC was confirmed by BODIPY/DAPI staining in which OP 
treatment resulted in a significant increase of neutral lipid content with respect to control 
(+121%; p ≤ 0.001).  Both CYS and EUC treatment significantly decreased lipid content in 
steatotic FaO cells by 30.2% and 29.6% with respect to OP (p≤0.05), while this decrease was 
not significant for FER treatment (Figure 25A). Qualitatively, same results were obtained with 






















































































           




    
Figure 25: A-Lipid droplet analysis by BODIPY staining in FaO cells (***p ≤ 0.001 with respect 
to control; # p ≤ 0.05 vs OP). B- Representative images of BODIPY (green)/DAPI (blue) staining 
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EFFECTS OF FUC ON GENES OF HEPATIC LIPID METABOLISM 
 
FaO cells express a wide range of liver specific mRNA which makes this cell line suitable for 
investigating the effect of FUC on key genes regulating hepatic lipid metabolism. Using qPCR, 
the expression of several genes was investigated; both lipogenic genes and genes implicated in 
FFA oxidation. 
Figure 26A shows the expression profile of lipogenic genes such as those coding for PPARs 
(Peroxisome Proliferator-Activated Receptors) transcription factors and for a family of LD-
associated proteins (perilipins, PLINs). The most abundant PPAR isoforms expressed in FaO 
cells are PPARα and PPARγ; results indicated that  OP treatment causes a slight increase in 
PPARα expression in steatotic FaO cells compared to control cells, and a return to control values 
after FUC treatment was apparent, but the results did not reach statistical significance. However, 
PPARγ expression was significantly induced by OP treatment (1.7-fold induction, p ≤ 0.01) and 
a significant down-regulation to control levels was measured after incubation with CYS, FER, 
and EUC by 42%, 50%, and 60%, respectively (p ≤ 0.001 with respect to OP). PLIN2 and PLIN5 
hepatic expressions are regulated by PPARγ. Accordingly, the mRNA levels of both PLINs are 
significantly increased in steatotic FaO cells with respect to control by (1.5- and 2.2- fold 
induction, p ≤ 0.01 and p ≤ 0.001, respectively). FUC treatment significantly downregulated the 
expression for PLIN2 and PLIN5 to control values: CYS (p ≤ 0.01, p ≤ 0.05); FER (p ≤ 0.01, p 
≤ 0.001); EUC (p ≤ 0.001. p ≤ 0.001), respectively.  
On the contrary, as shown in figure 26C genes encoding for proteins implicated in FFA oxidation 
such as CPT-1 and CYP4A1 were slightly overexpressed in OP cells by comparing to control 
(1.45 and 1.42 folds). CPT1 expression in steatotic cells did not show any difference when 
treated with FUC extracted from C. compressa, F. hermonis, and E. globulus, compared to 
untreated steatotic cells, while for CYP4A1, a further increase was observed only with EUC (p 
≤ 0.05 with respect to control).  
Moreover, expression of ApoB gene showed a slight increase upon OP treatment, and a 
subsequent treatment with EUC significantly increased its expression (p ≤ 0.001, p ≤ 0.05 with 
respect to control and OP, respectively), while CYS or FER treatment for steatotic cells did not 















     
 
 
   
Figure 26: Effects of CYS, FER and EUC on hepatic gene expression. The relative mRNA 
expression of A) PPARα and PPARγ, B) PLIN2 and PLIN5, C) CPT-1 and CYP41, and D) 
ApoB was quantified by qPCR in control (C) and steatotic FaO cells incubated in the absence 
(OP) or in the presence FUC of 50 µg/mL for 24 h. Data are expressed as fold induction with 
respect to controls (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 vs C; # p ≤ 0.05, ## p ≤ 0.01, ### p 














































































































































HECV (Human Endothelial Cord Vein Cells) 
                  ANTIOXIDANT EFFECTS in HECV CELLS 
 
CELL VIABILITY 
Results obtained by MTT assay showed that none of the purified FUCs tested at different (12.5-
100 µg/ml) exerts any cytotoxic effect on HECV cells; both in the absence and in the presence 
of OP.  The intermediate concentration 50 μg/mL of CYS, FER, and EUC was selected for further 
experiments. 
H2O2  treatment reduced cell viability  by 50.6 % with respect to control untreated cells (p ≤ 
0.001 with respect to control). Furthermore, FUCs pretreatment slightly restored the percentage 
of viable cells upon H2O2  treatment. 
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Figure 27: MTT assay 
results on HECV cells; 
A: steatotic and 
control HECV cells,  
B: H2O2 treated HECV 









➢ Steatotic HECV: Antioxidant capacities of FUC were confirmed by monitoring ROS 
production in steatotic HECV cells where ROS production was significantly increased by 
46 %  compared to control cells (p ≤ 0.05 with respect to control). Steatotic FaO cells pre-
treated with FUC purified from CYS and FER significantly decreased ROS production to 
become about the same as control cells (p ≤ 0.05 with respect to OP). EUC treatment lead 
to a further decrease in ROS concentration where this reduction was by 42 % compared to 
OP (p ≤ 0.01 with respect to OP).  
 
➢ H2O2 treated HECV cells: H2O2 treatment induces ROS production in HECV cells more 
than the steatotic model. H2O2 significantly increased ROS production by 91 % compared 
to control cells (p ≤ 0.001 with respect to C), while FUCs purified from C. compressa, F. 
hermonis, and E. globulus reduced H2O2 induced ROS production by 31.6 %, 35.2 %, and 
42.6 % ; respectively, as compared to only H2O2 treated cells. (p ≤ 0.01 with respect to 
H2O2). 
    
Figure 28: ROS production measured by DCF assay in HECV cells. A: Steatotic HECV cells; 
B: H2O2 treated HECV cells. (* p ≤ 0.05, *** p ≤ 0.001 vs C;  # p ≤ 0.05, ## p ≤ 0.01, ### p 
≤ 0.001 vs OP or H2O2).    
 
QUALITATIVE MEASUREMENTS  
H2O2 treated HECV cells showed an increased ROS production by 90 % compared to control 
cells (p ≤ 0.001 with respect to control). CYS, FER and EUC significantly suppressed ROS 
production by 31.8 %, 35.3 %, and 42.8 %, respectively (p ≤ 0.001 with respect to OP). These 
results were confirmed by microscopic qualitative analysis for the fluorescence emitted by DCF. 







































































intensity greater than that observed in control cells. Moreover, H2O2  did not induce ROS 
production in FUC treated cells as it was  in case of H2O2 treatment alone since CYS, FER, and 
EUC treated cells showed a reduced intensity as compared to  H2O2 treated cells.  
 
         H2O2 Treated cells 
 
     
         
 
 OP Treated Cells 
 
  
    
Figure 29: Representative images of DCF staining (green) to monitor ROS production in 
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                                 ANTI-STEATOTIC EFFECTS ON HECV CELLS. 
Anti-steatotic effects of FUC on endothelial cells were investigated by TAG content 
quantification in the same way as FaO cells.   
 
Spectrophotometrical analysis  
➢ Intracellular TAG content was quantified in both control (C) and steatotic HECV cells in 
the absence (OP) or presence of FUC (CYS, FER or EUC). As shown in Figure… OP 
treatment for 3 h significantly increased TAG content with respect to control (+200%; p ≤ 
0.01). However, steatotic cells treated with FUC showed a slight decrease in TAG content 
for CYS and FER as compared to OP by 5.7% and 14.3 %; respectively, while FUC 
purified from E. globulus results in a significant TAG content decrease by 30.2% (p ≤ 0.05 
with respect to OP).   
 
➢ Extracellular TAG content was significantly increased in steatotic cells by (+72%; p ≤ 
0.01) with respect to control cells. However, subsequent FUC treatment from the three 
different species did not significantly affect TAG secretion in HECV steatotic cells.  
 
   
Figure 30: TAG content quantification in HECV cells. (A: Intracellular TAG; B: Extracellular TAG). 




BODIPY/DAPI staining method for TAG quantification was validated also in steatotic HECV 
cells. As shown in figure 31 results indicated that OP treatment significantly increased TAG 
content by 35 % as compared to control cells (p ≤ 0.05). Steatotic endothelial cells pre-treated 




















































































                                      NITRIC OXIDE PRODUCTION 
NO production in HECV cells was measured indirectly by spectrophotometric quantification of 
the end products (nitrites and nitrates, collectively referred as NOx) using the Griess reaction as 
explained above. NO production in HECV cells was induced by OP or H2O2 treatment. 
➢ Steatotic HECV cells: As shown in Figure 32A, OP treatment also significantly enhanced 
NO production in HECV cells compared to control (+ 118%, p ≤ 0.001) and this increase 
was effectively reduced by FER, and EUC treatment by 32.5 and 40.7, respectively (p ≤ 
0.001 with respect to OP), while that caused by CYS treatment was not significant (16.5 
% with respect to OP).  
➢ H2O2 Treated HECV Cells: NO production was induced also by H2O2 treatment, in which 
NO release was increased by 60% as compared to control (p ≤ 0.001), and significantly 
reduced in HECV treated by CYS, FER, and EUC by 51%, 30% and 54%, respectively by 
comparing to only H2O2 treatment  (p ≤ 0.001 for both). 
 
   
Figure 32: NOx production measured by Griess assay in HECV cells. A: Steatotic HECV 

























































































Figure 31: Lipid droplet 
analysis by BODIPY 
staining in HECV cells (*p 









NAFLD is a physio-pathological condition affecting 25% of the population worldwide; it does 
not simply represent a fatty liver, because its worsening is a burden to the liver and extra-hepatic 
tissues as well, being closely associated with cardiovascular diseases (Adams et al., 2017). 
Previous studies showed the impact of a lipid- rich diet during pregnancy as it predisposes 
offspring for the later development of NAFLD (Hughes et al., 2014). Apart from dietary and 
lifestyle interventions, there is still a lack of therapies for NAFLD, and research is addressed to 
discover new natural compounds able to counteract NAFLD onset and progression, possibly 
without the side effects of synthetic drugs. The literature about algae as nutritional and functional 
food sources, is extremely rich (Wells et al., 2018) and FUC from different seaweeds are the 
most extensively studied algal polysaccharides in relation to NAFLD, showing efficacy both in 
vivo and in vitro experimental models, as we recently reviewed (El Rashed et al., 2020).  
Rat hepatoma FaO cells treated with a mixture of fatty acids (OP) represents an in vitro model 
of NAFLD, that we previously validate to study the molecular mechanisms underlying NAFLD 
onset and progression as well as putative therapeutic agents (Grasselli et al., 2017).  Our results 
indicated that FUC purified from three different species at low concentration (50 μg/mL) 
exhibited an anti-steatotic and anti-oxidant potentials illustrated by lowering intracellular TAG 
content in lipid-overloaded cells and down-regulating ROS production induced by excessive fat, 
respectively. 
Increased ROS production in steatotic hepatocytes due to ER stress, mitochondrial and 
peroxisomal dysfunction contribute to OS and inflammation development. The interaction of 
produced ROS with polyunsaturated fatty acids (PUFA); known as lipid peroxidation ends in 
formation of highly reactive aldehydes, such as malondialdehyde (MDA) and 4-hydroxy-2-
nonenal (4-HNE) that have longer half-lives than ROS. Furthermore, lipid peroxidation activates 
kupffer cells to release inflammatory cytokines such as TNF-α and IL-6. Thus, ROS might 
contribute to immunological dysfunction and inflammation, triggering NAFLD progression 
steatohepatitis, fibrosis cirrhosis, leading hepatocellular carcinoma in some cases (Ucar et al., 
2013) (Masarone et al., 2018) 
FaO cells are suitable to monitor lipid metabolism regulation as they express a wide range of 
liver specific genes which are involved in lipogenesis and FAs oxidation. Peroxisome 
proliferator-activated receptors (PPARs) are ligand-activated transcription factors playing a key 
role in the regulation of hepatic lipid balance, and their expression is targeted in NAFLD 
therapies (Mello 2015; liss et al., 2017).  
In previous studies, lipid over-loaded FaO steatotic cells showed an increased PPARγ expression 
(Grasselli et al., 2017). PPARγ is a marker of fatty liver and it is highly expressed in NAFLD to 
induce energy storage, as it mediates the activation of lipogenic genes (Rahimian et al., 2001). 
So, the mechanism of action for several drugs in down-regulating PPARγ expression was 
detected also by CYS, FER, and EUC treatment in which the results explain the decrease in 
intracellular TAG content.   
PPARγ regulate the expression of other genes such as PLIN2 and PLIN5 important for TAGs 





of LD-associated proteins that stabilize LDs formation and play important roles in their 
metabolism, thus trafficking lipid inside and outside the cell (Bickel et al., 2009; Kimmel et al., 
2010). In accordance with PPARγ expression profile, PLIN2 and PLIN5 expression was 
significantly enhanced in steatotic cells and decreased after FUC treatment from the three 
different species. Furthermore, accumulated neutral lipid percentage obtained from BODIPY 
staining measured by the fluorimeter, as well as their representative images indicate less LDs in 
FUC-treated steatotic cells.  
Concerning genes implicated in oxidative and/or secretion pathways, neither PPARα nor CPT-
1 expression was modified upon FUC treatment which means that FAs transport into 
mitochondria and their oxidation respectively were not affected. CYP4A1 plays a central role in 
microsomal ω- oxidation of fatty acid, and its expression does not significantly change in OP 
treated cells as obtained before by Vecchione et al. (Vecchione et al., 2016), while EUC 
treatment only cause a slight increase in CYP4A1 expression as compared to control, which 
means induction of FAs oxidation. Moreover, the secretion of TAGs as very low-density 
lipoproteins was altered only by EUC treatment in steatotic FaO cells, as it significantly induced 
ApoB gene expression, which codes for the main component of VLDL.   
Taken together, these results confirm the anti-steatotic action of FUC purified from C. 
compressa, F. hermonis and E. globulus realized by mechanisms that involve energy storage 
down-regulation and changes in LD trafficking, while only EUC stimulate microsomal oxidation 
of FAs and promote their secretion.  
Endothelial cells serve as a permeable barrier between blood vessels and tissues to regulate blood 
flow and allow energy supply, thus their proper functioning is pivotal while endothelial 
dysfunction plays a central role in different metabolic disorders such as obesity, impaired 
glucose metabolism, hypertension and dyslipidemia (Tziomalos et al., 2010).Moreover, 
endothelial cells are the most abundant non parenchymal cells in the liver where they are crucial 
for nutrients, lipids, and lipoproteins transfer. Miyao et al indicated that endothelial injury might 
have a “gatekeeper” role in NAFLD pathogenesis toward NASH (Miyao et al., 2015). 
Atherosclerosis defined as fat and cholesterol build up in the artery wall, initiates by a number 
of events being the most important is endothelial damage, and significantly associated with 
NAFLD (Thakur et al., 2012) .Therefore, anti-steatotic and anti-oxidant effects of CYS, FER, 
and EUC were investigated also in human endothelial cells (HECV). As shown previously, fatty 
acid treated HECV cells accumulate cytosolic lipids and could be considered as atherosclerosis 
model (Vergani et al. 2018). Our results confirmed lipid accumulation within HECV in which a 
significant increase in intracellular and extracellular TAG content in OP- treated cells. Exposure 
of fat enriched HECV cells to FUC purified from E. globulus significantly decreased 
intracellular TAG content and did not affect extracellular TAG content, while CYS and FER 
treatment did not modify lipid accumulation, neither intracellular nor extracellular one.  
OS in HECV cells was induced by OP and H2O2 treatment where ROS production was 
significantly increased in both cases. CYS, FER, and EUC treatment after OP or H2O2 incubation 





NO is a key cellular signaling molecule involved in a variety of biological functions throughout 
the whole body, at low concentrations it regulates leucocyte adhesion, platelet aggregation, 
vascular tone and blood flow by activating soluble guanylate cyclase in the vascular smooth 
muscle. Under pathological conditions like hypertension, atherosclerosis, and angiogenesis-
associated disorders, inducible nitric oxidase synthase expression is upregulated resulting in 
vascular NO overproduction and transport abnormalities (Luiking et al., 2010). Furthermore, 
previous studies indicated increased iNOS levels in NAFLD patients with significant hepatic 
steatosis as compared to those with lower score of steatosis (Elsheikh et al., 2017). In this study, 
FER and EUC significantly decreased NO production, after it was significantly induced by OP 
or H2O2 treatment. However, for CYS this reduction was significant only in H2O2 treated HECV 
cells.  
The difference in biological activities is related to structural variation which can be attributed to 
the environmental changes between plants and brown algae, species diversity, molecular weight, 
monosaccharide composition, extraction method, harvesting season, sulfate content, and sulfate 
content (Wang et al., 2019). At species level, E. globulus have gained more interest and more 
studies were done than C. compressa and F. hermonis to investigate the medicinal applications 
of these species. Previous studies showed that E. globulus has been used for treatment of various 
diseases such as fungal infection, diabetes, influenza, and pulmonary tuberculosis. Another study 
shows that the extract of E. globulus leaves reduced lipogenesis, inflammatory cytokine 
expression and OS, and inhibited NASH induced by fructose ingestion in rats (Takahashi et al., 
2015).  While for cystoseira compressa, previous studies have showed that C. compressa 
aqueous extracts have good anti-microbial, antioxidant, anti-inflammatory and anti-proliferative 
activities against HCT and MCF-7 cell lines (Mhadhebi et al., 2014).  FUC purified from C. 
compressa that showed gastroprotective effect and inhibited gastric lesions (Hadj Ammar et al., 
2015). Moreover, FUCs isolated from C. compressa exhibited a significant anti-inflammatory 
and antioxidant activity and a significant decrease of gastric mucosal damage. However, 
regarding F. hermonis, it has been shown that it exerts antibacterial, anti‐inflammatory, 
antidiabetic, hypolipidemic, and hepatoprotective effects. These biological activities are related 
to the presence of a wide range of active compounds such a sulfur‐containing compounds, 
sesquiterpenes, coumarins, ferutinin, α‐pinene, camphene and carvacrol, as well as vitamins (A 
and E) and some minerals (Sattar et al., 2017). According to the chemical composition reported 
by Abdel‐Kader et al. (Abdel‐Kader et al., 2011), F. hermonis roots contain 38.38% 
carbohydrates, 8.33% lipids, and 3.48% proteins. FUC obtained from E. globulus was 
characterized with the highest sulfate content as compared to the other two species,  as FUC with 
higher sulfate content exerts more anti-oxidant effect (li et al., 2008), confirming our results 
which states that EUC is the most potent antioxidant as compared to FUC and FER. Furthermore, 
the difference in sulfate position can affect FUC biological properties. Therefore, all these 
factors that mediate the therapeutic effects of the extracted polysaccharide results in making 
FUC purified from E. globulus with more antioxidant and anti-steatotic potentials than that 








   
 
In this study we were able to study the antioxidant and lipid lowering effect of FUC purified 
from Cystoseira compressa, Ferula hermonis, and Eucalyptus globulus.  These effects point to 
candidate FUC as a  possible bioactive compound against NAFLD progression towards more 
serious conditions and counteract the progression of OS disorders related to NAFLD such as 
atherosclerosis. . Fucoidan purified from E. globulus exhibited the most antioxidant and anti-
steatotic potentials using two cellular models. The biological properties of FUC are possibly 
linked to the pharmaceutical properties of the three vegetal sources of FUC that we analyzed 
(CYS, FER and EUC), which are widely used in popular medicine for a variety of diseases, 
including OS-associated pathologies such as inflammatory disorders, neurodegenerative 
























GENERAL CONCLUSIONS  
In this thesis, we purified FUC, the water soluble fucose sulfated polysaccharide, from the brown 
algae (C. compressa) collected from the Lebanese coast and the terrestrial plant (F. hermonis) 
harvested from the “Mountains of Bekaa” for the first time. Some structural and chemical 
compositional differences were determined between CYS, FER, and fucoidan purified 
previously from the terrestrial plant (E. globulus). E. globulus showed the highest content of 
fucose, sulfate and sugar. The structural difference may refer to the vegetal species and 
environmental conditions variation.  
FUC purified from the three species possess a potent antioxidant activity measured by different 
in vitro spectrophotometrical assays. 
Our cellular in vitro models were composed of hepatoma FaO cells and endothelial HECV cells 
incubated with Oleate/Palmitate mixture to induce steatosis and endothelial damage.  
The protective effect of FUC against OS was confirmed by preventing cell viability decrease 
caused by H2O2 incubation, and through lowering ROS production in FUC- treated steatotic FaO 
cells. Furthermore, ROS increased production in steatotic FaO, steatotic HECV, and H2O2 
treated HECV cell  was reduced upon CYS,FER, and EUC treatment.  
FUC reduces the lipid content in steatotic liver cells and in fat-enriched endothelial cells. The 
antisteatotic action exhibited in hepatocytes points to candidate FUCs as possible bioactive 
compounds against NAFLD onset and progression towards more serious conditions. The effect 
of counteracting lipid accumulation in endothelial cells may be associated with effective actions 
against atherosclerosis.   
In liver cells, the anti-steatotic effect of FUC is associated with a decrease in the expression of 
PPARγ, a known marker of hepatic steatosis and is implicated in the stimulation of lipogenesis. 
In accordance, the hepatic expression of ADRP and OXPAT, which are under the control of 
PPARγ and stabilize LDs, is decreased. These results suggest that the anti-steatotic effect of 
FUC is realized through an inhibition of DNL and an increase in hepatic LD turnover. Excess 
TAGs contained in LDs could be directed to secretion and/or oxidative pathways. Our results on 
gene expression pointed to a stimulation of oxidative pathway and secretion mechanisms for 
FUC purified from E. globulus where CYP4A1 and ApoB expression were induced.  
Furthermore, results indicated an increased level of nitric oxide production in fat enriched and 
H2O2 treated HECV endothelial cells.  CYS, FER, and EUC significantly decreased NO 
production, after it was significantly induced by OP or H2O2 treatment. This means that FUC 
ameliorates endothelial integrity and function.  
The difference in algal species, environmental variations, monosaccharide composition, 





of purified FUCs with EUC being the most potent polysaccharide in all experiments tested in 
this thesis.  
FUC displays a protective effect against oxidative damage in erythrocytes, hepatocytes, and 
endothelial cells. This is possibly linked to the pharmaceutical properties of the three vegetal 
sources of FUC that we analyzed (CYS, FER and EUC), which are widely used in popular 
medicine for a variety of diseases, including oxidative stress-associated pathologies such as 
inflammatory disorders, neurodegenerative conditions, diabetes, atherosclerosis, stroke, asthma 
and cancer. 
Thus, it can be concluded that an increased intake of FUC in the diet, either as dietary 
supplements or through an increased consumption of FUC-rich edible algae and plants, may help 
to counteract the onset or progression of oxidative stress-related disorders such as NAFLD and 
atherosclerosis.  
 
In the next steps, we would like to: 
➢ Investigate the anti-inflammatory effects of the three purified fucoidan.  
➢ Study the absorption of FUC, using human intestinal Caco-2 cells for example. 
➢ Anti-cancer activity of FUC (mainly EUC). 
➢ Study the biological activities using an in vivo model.   
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